This invention relates in general to medication administration or delivery devices. More particularly, the present invention relates to a novel system for maintaining drug or medication information, providing communication between a computer and one or more infusion pumps, and assuring the integrity of such information and communication.
Intravenous infusion therapy is prescribed where it is desirable to administer medications and other fluids directly into the circulatory system of a patient. Without alerts that warn the clinician that a higher or lower dose than clinical practice intended is being programmed, the resulting amount delivered to the patient can lead to increased morbidity or be fatal. There are various types of infusion pumps used by medical personnel to infuse medicinal fluids into a patient's body. There are very few pumps that have the feature of drug dose programming alerts. Some pumps use a customized drug library for electronically downloadable drug pumps. For example U.S. Pat. No. 6,269,340, which is incorporated by reference herein in its entirety, describes a system and computer readable medium for developing and downloading a customized drug library from a personal computer (PC) into an erasable, electronically loadable memory within the housing of a syringe pump. However, prior art systems and infusion pumps have several drawbacks. Following is a description of a novel infusion pump system that solves various problems found in the prior art.
The present invention relates to a system for communicating with one or more medication administration or delivery devices. More particularly, the invention relates to a system that utilizes a remote computer and a software program on a computer readable medium to download information to and/or upload information from one or more infusion pumps on a stand alone basis or as part of an integrated medication management system.
In one example, the software provides the remote computer with powerful drug library creation, editing, and archiving capabilities that can be used by a user, including but not limited to, a biomedical engineer, a pharmacist, a doctor, etc. A single drug formulary worksheet or database with each drug entry having an associated CCA designation can be created for the entire medical facility. The same drug may have different limits established in different clinical care areas and different device parameters and settings may be applied depending on the recommended best practices of the medical facility for a particular clinical care area. The single drug formulary worksheet is easier to control, update and maintain than a separate database or subdatabase for each clinical care area. In one example of the software, the software provides a real time rule set validator that dynamically validates entries into the drug formulary worksheet with each keystroke as the user keys in data. The user is instantly notified if a value exceeds an allowed range or if the data does not meet predetermined expected characteristics. In one example, the software also uses an extensible markup language for communications with the medication delivery devices. Communications between the computer and the devices may be validated using any desired technique(s), such as a cyclic redundancy check. In another example, a database is used to store the history of multiple infusion pumps. This enables the ability to retrieve the event log data from all pumps in one institution in one database, and being able to retrieve the data based on place of use, time, error types, etc. Other types of reports are also possible.
The software is useful, in one example, as a part of a system utilizing a computer to download information into and upload information from one or more medication delivery devices (such as infusion pumps). In one embodiment, the system includes a remote personal computer (PC) that has a memory for storing the software, a user interface, and display. The system also includes one or more infusion pumps and one or more techniques for connecting the PC to the pumps to facilitate the communication of information between the PC and the pumps. The infusion pumps can have single or multiple channels for delivering medications (i.e., fluids, medication, or mixtures thereof) to a patient. In one example, the information downloaded to the pumps can include, without limitation: a drug library with one or more drug entries typically grouped by clinical care area, drug delivery parameters (such as hard and soft limits), device settings, parameters or limits; patient specific information such as patient identification data; and caregiver specific information such as caregiver identification.
In one example, the software and the communication protocol utilize an open architecture that is adaptable to different versions, models and makes of medication delivery devices. In one embodiment of the present invention, the software is utilized in a system that establishes wired communication with a plurality of general purpose infusion pumps for downloading and uploading information. In other embodiments, the software is utilized in a system that establishes wireless communication with one or more general purpose infusion pumps having plug and play communication modules installed within the pump housing for downloading and uploading information. In other embodiments the plug and play communication module is integrally incorporated on an optional circuit board enclosed within the pump housing. Examples of medication delivery devices included, but are not limited to, single or multiple channel general purpose infusion pumps, patient controlled analgesia (PCA) pumps, ambulatory pumps, enteral pumps, IV infusion pumps, etc.
The software is also useful on a computer that interfaces with or acts as a medication management unit or server. In this example, the software facilitates communication between the PC and one or more medication delivery devices within a patient area network (PAN). Examples of what the communication between the PC and devices can be used for include, but are not limited to, downloading patient specific drug delivery instructions for operating and controlling the medication delivery device, and uploading information such as device characteristics, conditions, usage and alarm histories.
The present invention is illustrated by way of example and not limitation in the figures of the accompanying drawings, in which like references indicate similar elements.
In general, the present invention provides a system and method for providing communication between a computer and one or more medication administering devices. The invention uses hardware and software to provide the link between the computer and the infusion pumps. In one example, the invention is designed for use in a pharmacy or biomedical technical service environment or in a Medication Management Unit (MMU) as described in applicant's co-pending provisional application Ser. No. 60/527,583 entitled MEDICATION MANAGEMENT SYSTEM, filed Dec. 5, 2003 and the regular patent application by the same title, filed Feb. 20, 2004, which are expressly incorporated herein in their entirety.
The invention allows a facility to customize a drug library for use with an infusion pump, such as a PLUM A+® infuser or pump, available from Abbott Laboratories in Abbott Park, Ill. Other types of pumps may also be used with the present invention. For example, the invention may be used with patient-controlled analgesia (PCA) pumps, ambulatory pumps, enteral pumps, as well as IV infusion pumps. The invention also provides for storage of data from multiple pumps and generates various safety reports, events and alarm reports.
In one example, software of the present invention can store up to twelve Clinical Care Areas (CCAs) with up to 100 drug entries (99 drug entries and No Drug Selected) in each CCA for a total of 1200 entries in the Master Drug Formulary. In this example, the software of the present invention supports data transfer of up to fifteen Abbott PLUM A+® Single-Channel Infusers connected to a single computer. Of course, the invention can be designed with different storage and communication capabilities and be adapted for different pumps.
Referring to
After an active library is ready, a technician can connect one or more infusers 12 to the PC 10 for data transfer.
The present invention includes several features that solve various problems in the prior art. Following is a description of these features.
The present invention makes use of Extensible Markup Language (XML) representation for Remote Procedure Calls (RPC). One benefit of using XML is that the use of XML syntax documents allows the protocol to support different types of products. For example, a first infuser may only allow a certain communication format that is different from that required by another infuser. By using XML, the system can communicate with different types of infusers. Examples of different types of devices include devices with different computer architectures, devices running different types of computer processors, devices running different software programs (or different versions of the same program). In addition, some devices operate using a binary data format that may be incompatible with the binary format used on other devices. In this way, the host computer can use the same message formats for various different types of devices. The invention also provides the use of an XML parser in communicating with a patient-connected medical device, such as an infusion pump.
In some applications of the present invention, the host and the pump may have incompatible binary data formats. For this reason, it is necessary to define a lexical form that is the same on the host and the pump. This common lexical representation is called the canonical form. The process of converting from the processor-specific binary form to the canonical form is called canonicalization.
Error checking commonly uses checksum or hash functions. However, these functions are not always reliable. Since the present invention uses medically critical data, it is important to use a more reliable error checking function. In addition, it is desirable to allow partial library updates (such as an individual item in the drug library), while still being able to validate the content of the entire library. The present invention supplements standard checksum or hash function with a Global Canonical Cyclic Redundancy Check (gCCRC) which guards the state of the entire exchange data structure. Its purpose is to allow the host and pump to verify that their data is the same after attempted data transmission. The gCCRC can detect errors that are not trapped by lower level checksum and other methods. For example, the gCCRC can detect when the number of packets dropped is exactly the range of sequence numbers. The gCCRC also provides a final “backstop” validation against every sort of protocol failure, including exceptions like pump disconnection, power failure, and software defects.
In one example, rather than the conventional approach of comparing two binary images (an image at the host computer and an image at the infuser) to see if they are the same to validate the content of data stored in the infuser, a comparison is made to determine whether two possibly entirely different physical (bit-wise) representations are semantically the same. This is accomplished by using a canonical representation (which neither side actually uses for storage) and then doing the comparison between the two abstract representations. For example, to validate the contents of data in the infusion pump, a CRC is calculated based on the data in the pump. Next, a CRC is calculated based on what the host thinks the data in the pump is. Next, these numbers are compared. If the numbers are the same, it is highly likely that the data is the same at the host and at the infuser. One advantage to this approach is that only a small amount of data is required to be transferred for comparison purposes. A binary image of the entire library does not need to be retransmitted for comparison. This approach also eliminates the requirement of error checking during data transmission.
Another aspect of the present invention relates to how the CRC is calculated. The form of CRC used is specified by the Comite Consultatif Internationale de Telegraphique et Telephonique (CCIT). However, with the present invention, the CCIT CRC is done in the opposite bit order (right to left, versus left to right as specified by CCIT) so as to make the computation more efficient. It turns out that since Intel processors have the opposite “endianness” from the so-called “network byte order” prescribed by the CCIT, the bit reversal avoids some implementation problems on some processors.
When constructing the words (which may have different endianness) described above using CRC, it is important to precisely define the syntax of the document or data before using CRC. The present invention uses XML schema for this purpose. In addition, XML schema is used to define the semantics used for validation). The data to be validated (e.g., a drug library) is converted to its canonical form (described above) and validated and verified using the XML schema to determine whether the data is both valid and well formed. In the example of a library, this validation check occurs before transmitting the library to the pump.
One example of the XML schema of the present invention includes two main parts, exchange schema and implied schema. Generally, the exchange schema defines the structure of data to be communicated between a host computer and an infusion pump. The implied schema defines (and validates) the types of data being exchanged.
The implied data is a contract between the host computer 10 and the infusion pump 12. The implied data is managed by the host and used when developing software for the host and clients. In one example, the implied data is not transmitted over the communications link, nor does the infuser software ever process it. One purpose of the implied schema is to validate the value and types of data that are allowed to be passed to the client. One form of validation is range checking to restrict out of range values from being transmitted. Another form of validation can be display accuracy. For example, the display range of a variable can be tenths of digit. In such cases, sending a value of 12.00 would be invalid as it describes accuracy beyond the range of the variable. Another type of validation may be specific type checking. The implied schema takes the form of an XML schema document. The XML schema document provides type definitions for all the client/host specific type definitions in the exchange schema. The following are examples of various implied schema types. The first example is a simple string type schema, which defines an institution name string to be 30 characters or less.
XML schema supports fixed-point representations directly through a fractionDigits facet on most numeric data types. The following examples define minimum and maximum decimal and fraction digit values.
In one example, the present invention constructs an implied enumeration by defining an xs:enumeration restriction over an EncodedString.
Multiple ranges for a single value can be specified for a value via the <xs:choice> tag. The following examples relate to a patient weight field, including upper and a lower ranges.
t_PatientWeight
t_PatientWeight_0
t_PatientWeight_1
One issue with using XML is that XML is very verbose, which increases bandwidth requirements. To reduce communications overhead, the invention uses a more compact form of XML that is still standard compliant, but operates with significantly reduced bandwidth by abbreviating the XML identifiers to a few character mnemonics. The encoding is well formed XML that uses terse element and attribute names. In one example, each XML Short Name may consist solely of alphabetic characters and be uniquely identified by its first character. The commands pass arguments as XML attributes. The responses return values as attribute values and/or as elements nested inside the response element. For example, the long XML name “InfuserSetting” is shortened to “IS”. So, an exemplary line of commands might look like this:
rather than the non-compact version, which would look like this:
In this example, the encoding reduced approximately 200 characters to approximately 60 characters, yielding a ratio of about 3.3 to 1.
The present invention uses an extended data port protocol that includes a reliable binary transport protocol on top of the data port protocol. In other words, a protocol is run over the data port protocol. One advantage of this approach is improved compatibility between different machines. Another advantage is that large messages can be segmented and reassembled. This allows very large messages to be sent through the protocol stack, even if the host or pump cannot handle large messages. A large message will be segmented into small packets and later reassembled.
The invention assures the safety of the database by allowing only one library to be maintained in the computer that can be downloaded to pumps and is termed the active library. This assures that the wrong library is not downloaded over time. A library that can be edited is termed a worksheet and many different worksheets can exist. A library that was once active and is no longer active is archived and automatically designated as such. To be able transfer an active library to another computer a unique special file extension and recognition was developed. This allows for the transfer of the exact same library between pharmacies of a larger health care facility that may have multiple sites.
Another advantage of the present invention is that the system is capable of simultaneously downloading data to a plurality of infusion pumps. The library is transmitted in a multicast fashion to multiple pumps. The system will periodically verify the status of each pump using point to point communication. If one of the pumps has a problem, the download can be restarted, and each pump will be notified of the new download. In one example, when a pump detects a download error during a broadcast download, the pump sends a message to the host computer, which then halts the download. The host then polls all of the pumps to determine the point where all of the pumps received messages with valid data. Since the download takes place over multiple individual tagged messages, a tag number allows the host computer to identify the point where no pumps had reported a download error. When the download is continued, the download begins at this point, so all of the data does not have be downloaded again. The multicast communication strategy optimizes the download throughput. For example, if a library takes 10 minutes to download, 15 pumps can received the download in 10 minutes, as opposed to the 150 minutes it would take to download to each pump individually. This blend of multicast and point-to-point communication facilitates a robust download and a retry/recovery mechanism to individual pumps. Another advantage of the current invention is that the worksheet provides the pharmacists with a master formulary view at the same time providing for a CCA view of drug entries. Editing and copying of drug entries can be done in either view. This presentation promotes easy quality checks, a safety feature, for the pharmacist as drug or dosing limit alerts being developed. Errors in developing a drug library can lead to a reduced safety net for the nurses and increased patient morbidity.
Another advantage of the present invention is that a single database can be used to store the history of multiple infusion pumps. This enables the ability to retrieve the event log data from all pumps in one institution in one database, and being able to retrieve the data based on place of use, time, error types, etc. Other types of reports are also possible. Also, even with a centralized database, the system can include multiple PCs, which can each download to any desired pumps.
Similarly, the present invention is capable of collecting pump use data and generating related reports. For example, soft limit override data can be collected for the generation of a report relating to soft limit overrides. This type of report can be used for any desired purpose such as evaluating personnel, setting future limits, etc.
The present invention includes an active drug library editor that can validate drug data in real time. The invention is capable of managing an unlimited number of drug libraries. Drug libraries are configured with a Master Drug Formulary (the drug table from which CCAs are created) and multiple CCAs. Libraries can be active (a worksheet that has been finalized), archived (a previously active library that has been saved to the database) or a worksheet (a draft library that has not yet been approved for download to infusers and can still be edited). Only active libraries are allowed to be downloaded to a pump. Items such as configuration parameters that describe the operational behavior of a pump can be set pump-wide or specific to a CCA. These parameters are unique to each library. TallMan lettering is supported for drug names. Changes to TallMan lettering is replicated throughout a library. Each drug in the library is associated with a drug classification. Drug classifications are unique to each library. A drug may have multiple concentrations and multiple rule sets. Rule sets can be full, limited, or none.
Another feature of the present invention relates to the various levels of rules that the active drug library can utilize. The present invention allows the use of multiple rule levels including device rules (e.g., rules relating to the operation or limitations of a particular medical device or type of device), CCA rules (e.g., rules relating to the particular CCA), drug rules (rules relating to the particular drugs), and patient rules (e.g., rules relating to particular patients such as age, weight, health, medical history, allergies, etc.).
The Rule Set Editor (RSE) is used to create and edit rules sets in a drug database. RSE is responsible for accurately displaying rule sets and enabling the “Add”, “Save” or “Delete” buttons when appropriate.
Another advantage of the present invention relates to the drug configuration. The present invention includes a special rule set that allows the definition of a drug name and concentration for a particular drug. However, at the pump, a user can override the drug amount and drug unit. So, a limit is set, but a user is allowed to define the concentration. Therefore, the invention has the ability to selectively limit or allow the user to select the units of delivery on a drug-by-drug basis, and the ability to label a drug with concentration in drug units, but deliver in other units (such as ml/hr).
Another advantage of the present invention relates to constraint definitions. The invention includes a set of unique constraint objects. A constraint object defines a standard implementation for validating keyboard, mouse and import inputs. For example, a particular field may be constrained to a numerical range. The constraints prevent things from being done incorrectly. However, sometimes one object input is based on the content of another object and with the present invention constraint definitions change dynamically as input definitions change. For example, for the object “drug amount”, the constraint can change depending on the units of measure (e.g., grams, etc.).
Dose Rate Document (DRD) aggregates multiple constraints so that input verification can be cascaded through an unlimited number of constraint objects. In one example of an implementation of a DRD, the object DoseRateDocument extends javax.swing.text.PlainDocument to implement the required method insertString(int offset, String string, AttributeSet attributes). This method internally invokes StringConstraint.checkInput(String proposedValue) when appropriate.
Rule Set Constraints (RSC) provide specific DRDs for drug amount, diluent amount, and hard and soft limits. RSC are used to change these settings dynamically to validate inputs based on drug unit and dosing unit. RSC aggregates several constraint objects to verify that entries are within valid ranges. In one example, drugAmount, diluentAmount, and limits have their own DRD and Constraint object, but each is unique to meet the targets needs. RSC is initialized with default values when constructed. Successive calls to setDrugAmountConstraints(drugLabelPK) adjust the drugAmount DRD. Similarly, calls to setDiluentAmountConstraint( ) adjust the diluentAmount DRD. In one example of the present invention, the only constraint is diluentAmount. Likewise, successive calls to setLimitConstraints(dosingUnitPK) adjust the limit amounts.
Rule Set Data Item (RSDI) is a specialized DataItem and acts as a data model. Getter/Setters are provided to get and set attributes in the various forms needed by RVDC (described below), RSE and RSV (described below). DataItems know how to add themselves in a SQL Server database. In one example of the present invention, RSV is implemented as a static object and not a private implementation of RSDI. This separation of responsibility makes the implementation and maintenance of RSV simpler.
Rule Set Data Model (RSDM) is a specialized AbstractDataModel that provides a virtual data store for all RSDI items that are being imported.
Rate Versus Dose Calculations (RVDC) calculate the delivery rate corresponding to a given dose, in the context of such variables as patient weight, drug concentrations, etc. In one example, RVDC is not tied to a particular infusion pump implementation. Also, in one example, the RVDC algorithm is purely algebraic. RSDI owns the data that is extracted by RSV and passed to RVDC to calculate either calculateDoseFromRate or calculateRateFromDose.
The Rule Set Validator (RSV) orchestrates the validation process for all rule set data fields. The RSV starts by resetting the constraints needed by drugAmount, diluentAmount and the limits. It systematically validates each field for conformance, as follows:
RSV is used to validate rule sets from different sources, including: user input, imported libraries, copied drugs from one location to another, and makes adjustments to CCA maximum rate settings. RSV is consistently and constantly used throughout the system to validate that a rule set is well formed, valid and will not violate the delivery conformance for the entire library. If a user attempts to enter data that violate a rule, the “save” button in the dialog box will be dimmed and disabled, forcing the user to change the data that violates the rule.
Another feature of the present invention relates to Data Models. Data Models are used to import data into a drug library, copy from a source to a destination CCA library, and to edit CCA settings within a CCA Library. The following figures illustrate the relationship and high-level interactions between DrugLibraryManager (DLM) and RSDI.
The present invention also has a specialized combo box editor called the Dose Rate Editor (DRE). The DRE is used to establish the DRD for drugAmount, diluentAmount and the limits. The DRE is unique because it makes special allowances for both dose rate input and the reserved word ‘None’. The DRE converts all absolute values of zero (e.g., “0”, “0.0”, “0.00”, “none”, etc.) to ‘None’ and strips off any trailing zero or decimal points for non-zero values.
As mentioned before, the present invention is capable of using both hard and soft limits simultaneously. In addition, various related reports can be generated from one or more infusion pumps. One type of report is a soft limit override report (discussed below). Following is an example of how soft limit override reports can be generated. Persistent storage design for SoftLimit Alert/Override report is driven by both specific requirements for the “saving” of the uploaded logs and by the indirect requirements for parsing the raw log data to identify clinical action, partial events, and duplicate log entries. In one example, all log data maintains an association with the Infusion pump from which it was uploaded.
Raw log data is persisted both for archiving purposes and to support direct reporting (listing) of the log contents. Prior to its persistence, the raw log data undergoes a first pass of parsing to remove those portions of the log that represent old data that has already been uploaded to the PC but remained stored in the infusion pump (because the log is not cleared following an upload). The following database tables are defined to hold the parsed log data.
The first three tables listed, UploadHistory, UploadEvent, and EventType, support the existing functionality to persist the raw uploaded event data. The fourth table listed, ClinicalAction, is intended to provide the necessary context for an individual event (the Soft Limit Alert/Override) to generate a meaningful and useful report.
The individual fields of each of the tables described above are illustrated as follows. First, the fields from the UploadHistory are listed, along with a description of their purpose.
Next, the fields from the UploadEvent are listed, along with a description of their purpose.
Next, the fields from the EventType are listed, along with a description of their purpose.
Finally, the fields from the ClinicalAction are listed, along with a description of their purpose.
In one example, all of the fields listed are required and are constrained to be “not null”. In this example, all data fields support a value of “not available” to indicate that a specific field has no value because it could not be retrieved from the event log (e.g. due to overwriting when the log exceeds 321 lines). The following diagram illustrates the data model to support the Soft Limit Alert or Override clinical event.
One advantage of the present invention is that both hard and soft limits can be provided for each drug, and any drug/CCA combination can be ascribed one, two, three, or four limits. When the capability of providing both hard and soft limits exists, there the sixteen combinations of limits that can be used. Each of the four limits can contain a value specifying a limit, or the “limit” can be unrestricted (indicated by None in the appropriate field). These two possibilities exist for each limit, i.e., the lower hard limit, lower soft limit, upper soft limit and upper hard limit). This feature allows a user to configure a device in various combinations, such as a hard upper limit only, hard and soft upper and lower limits, hard and soft upper limits (no lower limits), hard and soft lower limits (no upper limits), etc. In the example of two sets of upper and lower limits, there are 16 possible combinations of configurations. If additional sets of limits are used, more combinations are possible. In one embodiment, hard limits are the upper and/or lower dose limits for the selected drug and selected CCA that cannot be overridden by a user. The hard limit in another embodiment may require or allow supervisory override. The hard limits, authority levels, and overridability, are defined by a hospital for each drug in its drug library. The hard limits for a particular drug may vary across different CCAs, if assigned.
In one embodiment, soft limits are upper and/or lower dose limits for the selected drug and selected CCA that can be overridden by a user. Soft limits for a particular drug, if assigned, may vary across CCAs. A set of rules is provided for the drug library that triggers alerts or warnings when soft limits are reached. The warnings require an explicit override step on the part of the operator. Similarly a set of rules is provided for the drug library that provide hard limits on the range of delivery rates the user is allowed to program. For example, if a lower soft limit is set to 10 mL/hr and the clinician enters 9 mL/hr, the infuser will display a soft limit override alert. This alert, which is recorded in the infuser's history log, notifies the clinician that the entry is outside the range of the soft limits set for that drug entry. The clinician can choose to continue programming using the override, or cancel the override and re-enter another value. If the clinician chooses to override the soft limit, the event is recorded separately in the infuser's history log. Hard and soft limits can be set on various other drug parameters. Examples include a dosage rates, drug delivery time, drug concentration, the weight of a patient, the volume to be infused (VTBI), etc.
Another use of hard and/or soft limits relates to correct data entry. For example, a hard limit can be set on time period entries so that a user can only enter values between 0 and 59. In this example, the system will realize a data entry error and force the user to enter a value in the valid range. In another example, for various drug fields, only certain values or ranges will be allowed to be entered. 15A shows examples of values that may be entered for drug unit, drug amount, diluent amount, delivery dose/rate units, and hard and soft limit fields. If a user attempts to enter other values, the system will force the user to enter a valid field, or will generate an alert or alarm.
The invention also allows the import and export of drug libraries from one computer to another. Before a library can be imported, it must be exported. Generally, a drug library can be exported to a finalized drug Library (FDL) having a predefined format, which makes the library safely and securely portable to other computers where they can be imported and set as an active library. For example, for a first PC having an active library, the library can be exported into a binary format, and moved (via a network, computer readable media, etc.) to a second PC, where it is imported, therefore synchronizing the libraries at the first and second PCs. The special file extension (FDL) and recognition by the software between computers is required.
When an FDL is exported, the entire drug library is first “selected” from the database, using the SelectEntireDrugLibrary stored procedure (see below). That procedure actually contains several select statements, with one statement per table. The tables are the same as for copy. For each table, the export method serializes the table name, number of rows and columns, then each row is serialized, column by column. Note that the original database index values are serialized. When the library is read from the file, the index values will no longer be valid—but should be mapped, the same as if the library were being copied. In one example, the FDL Files are “read only” files. Since the FDL files are in Java-serialized format, a FDL file is not easily modified by a user with ordinary software applications. This feature is part of the reason for using serialization—to discourage users from tampering with finalized drug libraries.
When an FDL is imported, first all the serialized information is read into memory, in the form of a three-dimensional array. There are three array dimensions, one dimension for the tables, one dimension for the rows, and one dimension for the columns. The sizes of the row and column dimensions may be different for each table. This “raw” data is inserted into the database, table-by-table, row-by-row. Also, index mappings may be performed along the way. Next, as the rows are inserted, new index values will be generated, and are stored in a map, similar to what happens during the copy operation. Some tables may contain indexes to other, previously inserted tables. These indexes are converted from the original values to the new values, using the generated map. These converted index values are the ones that are inserted into the new rows. After an FDL has been stored in the database, it becomes the Finalized Drug Library, making another Finalized Drug Library into an Archived library.
Following is a description of FDLData.java, which lets the FDL import know which order the tables are stored in the array, what the index dependencies are, which columns to store in the map, which column values need to be mapped to new values before they can be inserted, etc.
It is important to realize that, just as with copying a drug library, the order in which tables are processed during an FDL import is important. That order is encoded in the FDLData.java file as enumerated constants. Following is an example of such enumerated constants:
These constants can be used as indexes into the three-dimensional array of raw data described above. This section of code may also be generated by the PostSchemaChange.sql file, in case changes have been made to the database schema.
For each table that gets exported/imported there is an instance of TableInfo, which keeps track of the table name, the number of columns, which of its columns, if any, other tables might depend on (the idColumn), and finally, a set of indexes to tables that this table depends on. The “idColumn”, if specified, is generated by the database for each row of that table, as the rows are inserted. The old value (from the serialized file) and the new value (from the database row insertion) are stored in an index map. Then, every other in-memory table that references the old index is updated to contain the new index before its rows are inserted. For example, the “idColumn” of the RuleSet table shown below is its RuleSetID column, which happens to be the 2nd column in the TableInfo table. Thus, the “idColumn” in the TableInfo instance for RuleSet equals 1 (the first column is 0, the 2nd column is 1, . . . ). Now, assume that when the FDL was exported, there was a row in the RuleSet table where the RuleSetID was equal to 5047:
RuleSet (Slightly Simplified):
The CcaLibrary and DrugFormulary tables (shown below) each have a RuleSet dependency—their RuleSetID columns.
CcaLibrary (Slightly Simplified):
Drug Formulary:
Now assume that when the FDL is imported, that particular row of the RuleSet table (shown below) is given a new index value of 5122.
RuleSet (Slightly Simplified):
Later, before the CcaLibrary or DrugFormulary tables are inserted, any RuleSetID values of 5047 are first changed to 5122. The “idColumn” setting of 1 tells the FDL import code to store the 5047 to 5122 mapping.
Mapping (In Memory, Not a Database Table):
The 5047 values in the CcaLibrary and DrugFormulary tables are changed to 5122 while they are still in memory—in the three dimensional table of raw data. After those tables have been processed, the CcaLibrary and DrugFormularyID tables are shown below.
CcaLibrary (Slightly Simplified):
Drug Formulary:
Referring back to the FDLData.java file, various sections of the file are automatically generated by the PostSchemaChange.sql file. They can be cut and pasted from the output of that file into the java code. Specifically, the table order constants (as shown above), and the TableInfo array and its contents can be generated in the event of a database schema change.
The PostSchemaChange.sql file also generates most of the SelectEntireDrugLibrary stored procedure (described below) at the same time. Again, the SQL code it generates can be cut and pasted into the proper place in the SelectEntireDrugLibrary.sql file.
When a FDL is to be exported, the data that makes up the library is obtained from the database (so it can be serialized to a file). The SelectEntireDrugLibrary stored procedure does that. The procedure utilizes several select statements, selecting the tables in a specific order, and selecting the columns of any given table in a specific order.
Since the order of the tables, and the order of the columns within those tables is important to the FDL import code that reconstructs a drug library, it is essential that the FDL export, FDL import, and SelectEntireDrugLibrary code be kept in sync with each other. The slightest change in the database schema can necessitate changes in FDLData.java and SelectEntireDrugLibrary, as well as the CopyDrugLibrary stored procedure. The slightest error (mismatch) will stop things from working properly.
Except for the CopyDrugLibrary code, most of the java and SQL changes can be produced by running the PostSchemaChange.sql file after the new schema is in place. Simply cut and paste the generated code over the matching/similar code in those files. The CopyDrugLibrary code changes can also be automated.
One feature of the present invention is that data can be imported to and exported from the system. Library text files that use either Comma Separated Values (CSV) or Tab Separated Values (TSV) can be imported by the system. One unique feature is the entire file must pass the RSV checks specified above or the entire import is considered invalid.
It will be appreciated by one skilled in the art that the present invention is applicable to a variety of pumps or medical devices and not limited to the pumps with which it is described herein. Furthermore, one skilled in the art will appreciate that the connections between the pumps and the computer could be wireless or hard-wired, without detracting from the invention. Wireless communication engines can be connected to the pump and the computer and use a wireless network utilizing communication protocols such as BLUETOOTH™ (IEEE 802.15) or other protocols such as those described in IEEE 802.11, 802.11a, 802.11b, and 802.11g. Communication within the wireless network may utilize radio frequency electromagnetic radiation, infrared radiation, or other means for accomplishing wireless communication between network elements.
In one example, the plug and play module 4 can house or encase a wireless communication or connectivity engine. Conventional wireless communication modules for medical pumps have been of the external plug-in, bolt-on type for optimal reception and transmission. These conventional communications modules add significantly to the space required for the pump and alter its profile. They can be damaged or dislodged if the pump is dropped. Furthermore, there are stringent standards for maximum electrical emissions from medical equipment to prevent potential interference with other medical equipment. The wireless plug and play module 4 of the present invention does not substantially increase the space occupied by the pump. With the improved antenna design described below, placing the plug and play module 4 inside the pump housing 2 still provides good position/orientation tolerant reception and transmission characteristics and provides the surprising result of lower, better controlled electronic emissions from the device.
As mentioned above, an infusion pump of the present invention is capable of being connected to various other devices. In one example, the present invention uses a connectivity engine to provide system functions, in addition to enabling a pump to connect to a variety of other devices. Following is one example of a connectivity engine which can be used with the present invention. In the example described, the various features and capabilities can be customized as desired.
The connectivity engine is an assembly inside the housing of an infuser with the purpose of providing key system functions and enabling the infuser to connect to a variety of external systems including medication management units (MMU), hospital information systems (HIS), pharmacy information system (PhIS), and other medical information systems through both wired and wireless communication links. The connectivity engine can interface via data and address buses on its printed wiring assembly to the CPU printed wiring assembly via a board to board connector. In one example, the connectivity engine supports about 1-2 Mbytes of read-only program and 1 M-byte or more of read/write data memories for the infuser CPU printed wiring assembly. The connectivity engine can communicate with a host computer via a serial data port, which is externally located on the rear of the infuser unit. In one example, the data port is electrically isolated.
In this example, the connectivity engine includes a front panel lockout switch, which is externally accessible on the rear of the unit. The connectivity engine may also include a nurse call interface, which is externally located on the rear of the unit. The nurse call interface allows use with a nurse call device, such as a switch held by a patient that allows the patient to send an alarm message to a nurse. The connectivity engine may also include an alarm volume control, which is accessible from the rear of the instrument. This control will adjust the volume level for an audible alarm to alert the user to errors, warnings, etc.
The connectivity engine is a modular and intelligent printed wiring assembly capable of supporting the interconnection of an infuser with a variety of external systems for the purpose of establishing bi-directional communications between the infuser and external systems. Examples of external systems may include medication management units (MMU), medical information systems, HIS, and external wireless Access Points. Other examples of external systems include one or more PCs for downloading drug libraries and software to the infuser and uploading logs from the infuser.
As mentioned above, the present invention is capable of both wired and wireless communications. Examples of wired interfaces that may be supported include Ethernet 10BaseT and 100BaseT standard, as well as Megabit and fiber optic interfaces. Examples of wireless interfaces that may be supported include IEEE802.11a/b/g, as well as any other desired interfaces. The connectivity engine can support various network protocols, including XML, HTML, ftp, and Telnet services.
In one example, the present invention normally operates using either a wired or wireless interface. In another example, the invention can simultaneously use both wired and wireless interfaces. In this example, when a fault is detected in either mode, all communications automatically can switch to the working mode.
The connectivity engine hardware can take on many forms, depending on the functionality and capabilities desired. In one example, the connectivity engine includes the following sub-circuits: CPU memory—RAM and flash, external serial interface, nurse call interface, audio volume control, lockout switch, connectivity engine controller, Ethernet interface, wireless interface, and antenna assembly. The following external connectors can also be included: Ethernet RJ-45 connector, RF connector for connecting the Wi-Fi transceiver to the Antenna printed wiring assembly, RS232 serial port DB9 connector, and Nurse Call Interface connector.
The RF transceiver 34 is shown with two antennas 36 and 38. While the present invention may include just one antenna, two antennas can improve the performance of the invention. Since the communication between the invention and other devices can be critical, it is desirable to provide the most reliable wireless connection possible. Two diverse antennas optimize the wireless communication coverage of the invention. The invention uses a combination of two different diversity schemes, spatial diversity and pattern diversity. Traditionally, in spatial diversity two identical antennas are located at two separate locations to provide diversity reception to a common receiver. In this case, the scheme not only separates the antennas physically but also achieves pattern diversity by placing the two antennas orthogonally. This way, peaks in one antenna fill out the nulls of the other antenna such that that combined radiation pattern looks more omnidirectional than just a single antenna. The antenna diversity scheme achieves several objectives. First, it is desirable to have the antenna(s) not so apparent externally, making it desirable to use an internally embedded antenna(s). Second, in most applications, the invention must meet the EMC requirements specified in the IEC 60601-1-2, 2nd Edition standard, which limits the amount of emissions a device can emit. The use of two diverse antennas helps to achieve these objectives. In one example, the antenna(s) used with the present invention are enclosed within the housing of the infusion pump. This help to keep dirt, harmful solvents and debris away from the antennas, enhances control of emissions, as well as reduces the chance of damage to an antenna.
In another example, the connectivity engine includes memory used as cache for temporarily storing information. The cache can make the system work more efficiently and more reliably.
In the preceding detailed description, the invention is described with reference to specific exemplary embodiments thereof. Various modifications and changes may be made thereto without departing from the broader scope of the invention as set forth in the claims. The specification and drawings are, accordingly, to be regarded in an illustrative rather than a restrictive sense.
This application claims priority based upon U.S. Nonprovisional application Ser. No. 10/783,877 filed Feb. 20, 2004 and U.S. Provisional Application Ser. No. 60/519,646 filed Nov. 13, 2003 and U.S. Provisional Application Ser. No. 60/527,550 filed Dec. 5, 2003, which are expressly incorporated herein in their entirety.
Number | Name | Date | Kind |
---|---|---|---|
4024864 | Davies et al. | May 1977 | A |
4055175 | Clemens et al. | Oct 1977 | A |
4151845 | Clemens | May 1979 | A |
4213454 | Shim | Jul 1980 | A |
4240438 | Updike et al. | Dec 1980 | A |
4280494 | Cosgrove et al. | Jul 1981 | A |
4308866 | Jeliffe | Jan 1982 | A |
4370983 | Lichtenstein et al. | Feb 1983 | A |
4373527 | Fischell | Feb 1983 | A |
4392849 | Petre et al. | Jul 1983 | A |
4395259 | Prestele et al. | Jul 1983 | A |
4457751 | Rodler | Jul 1984 | A |
4464170 | Clemens | Aug 1984 | A |
4469481 | Kobayashi | Sep 1984 | A |
4475901 | Kraegen et al. | Oct 1984 | A |
4494950 | Fischell | Jan 1985 | A |
4498843 | Schneider et al. | Feb 1985 | A |
4515584 | Abe et al. | May 1985 | A |
4526568 | Clemens et al. | Jul 1985 | A |
4529401 | Leslie et al. | Jul 1985 | A |
4543955 | Schroeppel | Oct 1985 | A |
4551133 | Zegers de Beyl et al. | Nov 1985 | A |
4553958 | LeCocq | Nov 1985 | A |
4559037 | Franetzki et al. | Dec 1985 | A |
4613937 | Batty | Sep 1986 | A |
4624661 | Arimond | Nov 1986 | A |
4633878 | Bombardieri | Jan 1987 | A |
4634426 | kamen | Jan 1987 | A |
4634427 | Hannula et al. | Jan 1987 | A |
4674652 | Aten et al. | Jun 1987 | A |
4676776 | Howson et al. | Jun 1987 | A |
4679562 | Luksha | Jul 1987 | A |
4685903 | Cable et al. | Aug 1987 | A |
4695954 | Rose | Sep 1987 | A |
4696671 | Epstein et al. | Sep 1987 | A |
4714462 | DiDomenico | Dec 1987 | A |
4722734 | Kolin | Feb 1988 | A |
4731051 | Fischell | Mar 1988 | A |
4741732 | Crankshaw et al. | May 1988 | A |
4756706 | Kerns et al. | Jul 1988 | A |
4776842 | Franetzki et al. | Oct 1988 | A |
4785969 | McLaughlin | Nov 1988 | A |
4803625 | Fu et al. | Feb 1989 | A |
4835372 | Gombrich et al. | May 1989 | A |
4838275 | Lee | Jun 1989 | A |
4838856 | Mulreany et al. | Jun 1989 | A |
4838857 | Strowe et al. | Jun 1989 | A |
4854324 | Hirschman et al. | Aug 1989 | A |
4857716 | Gombrich et al. | Aug 1989 | A |
4858154 | Anderson et al. | Aug 1989 | A |
4898578 | Rubalcaba, Jr. | Feb 1990 | A |
4908017 | Howson et al. | Mar 1990 | A |
4933873 | Kaufman et al. | Jun 1990 | A |
4943279 | Samiotes et al. | Jul 1990 | A |
4946439 | Eggers | Aug 1990 | A |
4953745 | Rowlett | Sep 1990 | A |
4978335 | Arthur, III | Dec 1990 | A |
5000739 | Kulisz et al. | Mar 1991 | A |
5010473 | Jacobs | Apr 1991 | A |
5014698 | Cohen | May 1991 | A |
5016172 | Dessertine | May 1991 | A |
5026084 | Paisfield | Jun 1991 | A |
5034004 | Crankshaw | Jul 1991 | A |
5041086 | Koenig et al. | Aug 1991 | A |
5058161 | Weiss | Oct 1991 | A |
5078683 | Sancoff et al. | Jan 1992 | A |
5084828 | Kaufman et al. | Jan 1992 | A |
5088981 | Howson et al. | Feb 1992 | A |
5097505 | Weiss | Mar 1992 | A |
5100380 | Epstein et al. | Mar 1992 | A |
5102392 | Sakai et al. | Apr 1992 | A |
5104374 | Bishko et al. | Apr 1992 | A |
5109850 | Blanco et al. | May 1992 | A |
5131816 | Brown | Jul 1992 | A |
5142484 | Kaufman et al. | Aug 1992 | A |
5153827 | Coutre et al. | Oct 1992 | A |
5157640 | Backner | Oct 1992 | A |
5161222 | Montejo et al. | Nov 1992 | A |
5177993 | Beckman et al. | Jan 1993 | A |
5181910 | Scanlon | Jan 1993 | A |
5190522 | Wocicki et al. | Mar 1993 | A |
5199439 | Zimmerman et al. | Apr 1993 | A |
5200891 | Kehr et al. | Apr 1993 | A |
5216597 | Beckers | Jun 1993 | A |
5221268 | Barton et al. | Jun 1993 | A |
5230061 | Welch | Jul 1993 | A |
5243982 | Möstl et al. | Sep 1993 | A |
5244463 | Cordner, Jr. et al. | Sep 1993 | A |
5249260 | Nigawara et al. | Sep 1993 | A |
5256156 | Kern et al. | Oct 1993 | A |
5256157 | Samiotes et al. | Oct 1993 | A |
5261702 | Mayfield | Nov 1993 | A |
5317506 | Coutre et al. | May 1994 | A |
5319355 | Russek | Jun 1994 | A |
5319363 | Welch et al. | Jun 1994 | A |
5330634 | Wong et al. | Jul 1994 | A |
5338157 | Blomquist | Aug 1994 | A |
5341476 | Lowell | Aug 1994 | A |
5364346 | Schrezenmeir | Nov 1994 | A |
5366346 | Danby | Nov 1994 | A |
5368562 | Blomquist et al. | Nov 1994 | A |
5373454 | Kanda et al. | Dec 1994 | A |
5376070 | Purvis et al. | Dec 1994 | A |
5378231 | Johnson et al. | Jan 1995 | A |
5389071 | Kawahara et al. | Feb 1995 | A |
5389078 | Zalesky et al. | Feb 1995 | A |
5417222 | Dempsey et al. | May 1995 | A |
5423748 | Uhala | Jun 1995 | A |
5429602 | Hauser | Jul 1995 | A |
5431627 | Pastrone et al. | Jul 1995 | A |
5432777 | Le Boudec et al. | Jul 1995 | A |
5445621 | Poli et al. | Aug 1995 | A |
5447164 | Shaya et al. | Sep 1995 | A |
5455851 | Chaco et al. | Oct 1995 | A |
5461365 | Schlager et al. | Oct 1995 | A |
5464392 | Epstein et al. | Nov 1995 | A |
5465082 | Chaco | Nov 1995 | A |
5485408 | Blomquist | Jan 1996 | A |
5486286 | Peterson et al. | Jan 1996 | A |
5493430 | Lu et al. | Feb 1996 | A |
5496273 | Pastrone et al. | Mar 1996 | A |
5505828 | Wong et al. | Apr 1996 | A |
5507288 | Bocker et al. | Apr 1996 | A |
5507786 | Morgan et al. | Apr 1996 | A |
5508499 | Ferrario | Apr 1996 | A |
5515713 | Saugues et al. | May 1996 | A |
5520637 | Pager et al. | May 1996 | A |
5522798 | Johnson et al. | Jun 1996 | A |
5547470 | Johnson et al. | Aug 1996 | A |
5554013 | Owens et al. | Sep 1996 | A |
5562615 | Nassif | Oct 1996 | A |
5577169 | Prezioso | Nov 1996 | A |
5582323 | Kurtenbach | Dec 1996 | A |
5582593 | Hultman | Dec 1996 | A |
5594786 | Chaco et al. | Jan 1997 | A |
5598519 | Narayanan | Jan 1997 | A |
5620608 | Rosa et al. | Apr 1997 | A |
5630710 | Tune et al. | May 1997 | A |
5636044 | Yuan et al. | Jun 1997 | A |
5643212 | Coutre et al. | Jul 1997 | A |
5651775 | Walker et al. | Jul 1997 | A |
5658131 | Aoki et al. | Aug 1997 | A |
5658250 | Blomquist et al. | Aug 1997 | A |
5665065 | Colman et al. | Sep 1997 | A |
5669877 | Blomquist | Sep 1997 | A |
5672154 | Sillén et al. | Sep 1997 | A |
5681285 | Ford | Oct 1997 | A |
5685844 | Marttila | Nov 1997 | A |
5687717 | Halpern et al. | Nov 1997 | A |
5689229 | Chaco et al. | Nov 1997 | A |
5697899 | Hillman et al. | Dec 1997 | A |
5699509 | Gary et al. | Dec 1997 | A |
5713856 | Eggers et al. | Feb 1998 | A |
5718562 | Lawless et al. | Feb 1998 | A |
5719761 | Gatti et al. | Feb 1998 | A |
5733259 | Valcke et al. | Mar 1998 | A |
5738102 | Lemelson | Apr 1998 | A |
5744027 | Connell et al. | Apr 1998 | A |
5752621 | Passamante | May 1998 | A |
5754111 | Garcia | May 1998 | A |
5764034 | Bowman et al. | Jun 1998 | A |
5764159 | Neftel et al. | Jun 1998 | A |
5772635 | Dastur et al. | Jun 1998 | A |
5774865 | Glynn | Jun 1998 | A |
5778256 | Darbee | Jul 1998 | A |
5778345 | McCartney | Jul 1998 | A |
5781442 | Engleson et al. | Jul 1998 | A |
5782805 | Meinzer et al. | Jul 1998 | A |
5788669 | Peterson | Aug 1998 | A |
5797515 | Lift et al. | Aug 1998 | A |
5800387 | Duffy et al. | Sep 1998 | A |
5814015 | Gargano et al. | Sep 1998 | A |
5822544 | Chaco et al. | Oct 1998 | A |
5822715 | Worthington et al. | Oct 1998 | A |
5827179 | Lichter et al. | Oct 1998 | A |
5832448 | Brown | Nov 1998 | A |
5836910 | Duffy et al. | Nov 1998 | A |
5850344 | Conkright | Dec 1998 | A |
5867821 | Ballantyne et al. | Feb 1999 | A |
5870733 | Bass et al. | Feb 1999 | A |
5871465 | Vasko | Feb 1999 | A |
5873731 | Predergast | Feb 1999 | A |
5885245 | Lynch et al. | Mar 1999 | A |
5897493 | Brown | Apr 1999 | A |
5897498 | Canfield, II et al. | Apr 1999 | A |
5910252 | Truitt et al. | Jun 1999 | A |
5912818 | McGrady et al. | Jun 1999 | A |
5915240 | Karpf | Jun 1999 | A |
5920054 | Uber, III | Jul 1999 | A |
5920263 | Huttenhoff et al. | Jul 1999 | A |
5924074 | Evans | Jul 1999 | A |
5931764 | Freeman et al. | Aug 1999 | A |
5935099 | Peterson et al. | Aug 1999 | A |
5935106 | Olsen | Aug 1999 | A |
5941846 | Duffy et al. | Aug 1999 | A |
5956501 | Brown | Sep 1999 | A |
5957885 | Bollish et al. | Sep 1999 | A |
5960085 | de la Huerga | Sep 1999 | A |
5961448 | Swenson et al. | Oct 1999 | A |
5967559 | Abramowitz | Oct 1999 | A |
5971594 | Sahai et al. | Oct 1999 | A |
5975081 | Hood et al. | Nov 1999 | A |
5990838 | Burns et al. | Nov 1999 | A |
5997476 | Brown | Dec 1999 | A |
6000828 | Leet | Dec 1999 | A |
6003006 | Colella et al. | Dec 1999 | A |
6012034 | Hamparian et al. | Jan 2000 | A |
6017318 | Gauthier et al. | Jan 2000 | A |
6021392 | Lester et al. | Feb 2000 | A |
6024539 | Blomquist | Feb 2000 | A |
6032155 | de la Huerga | Feb 2000 | A |
6032676 | Moore | Mar 2000 | A |
6073106 | Rozen et al. | Jun 2000 | A |
6104295 | Gaisser et al. | Aug 2000 | A |
6112182 | Akers et al. | Aug 2000 | A |
RE36871 | Epstein et al. | Sep 2000 | E |
6115390 | Chuah | Sep 2000 | A |
6122536 | Sun et al. | Sep 2000 | A |
6126637 | Kriesel et al. | Oct 2000 | A |
6135949 | Russo et al. | Oct 2000 | A |
6150942 | O'Brien | Nov 2000 | A |
6151643 | Cheng et al. | Nov 2000 | A |
6157914 | Seto et al. | Dec 2000 | A |
6159147 | Lichter et al. | Dec 2000 | A |
6167567 | Chiles et al. | Dec 2000 | A |
6182667 | Hanks et al. | Feb 2001 | B1 |
6189105 | Lopes | Feb 2001 | B1 |
6195589 | Ketcham | Feb 2001 | B1 |
6208974 | Campbell et al. | Mar 2001 | B1 |
6222323 | Yamashita et al. | Apr 2001 | B1 |
6223440 | Rashman | May 2001 | B1 |
6226277 | Chuah | May 2001 | B1 |
6227371 | Song | May 2001 | B1 |
6234176 | Domae et al. | May 2001 | B1 |
6241704 | Peterson et al. | Jun 2001 | B1 |
6248067 | Causey, III et al. | Jun 2001 | B1 |
6249705 | Snell | Jun 2001 | B1 |
6257265 | Brunner et al. | Jul 2001 | B1 |
6259355 | Chaco et al. | Jul 2001 | B1 |
6269340 | Ford et al. | Jul 2001 | B1 |
6270455 | Brown | Aug 2001 | B1 |
6271813 | Palalau | Aug 2001 | B1 |
6277072 | Bardy | Aug 2001 | B1 |
6280380 | Bardy | Aug 2001 | B1 |
6283761 | Joao | Sep 2001 | B1 |
6285665 | Chuah | Sep 2001 | B1 |
6292860 | Cochcroft, Jr. | Sep 2001 | B1 |
6312378 | Bardy | Nov 2001 | B1 |
6327254 | Chuah | Dec 2001 | B1 |
6330008 | Razdow et al. | Dec 2001 | B1 |
6339718 | Zatezalo et al. | Jan 2002 | B1 |
6346886 | de la Huerga | Feb 2002 | B1 |
6363282 | Nichols et al. | Mar 2002 | B1 |
6371719 | Hildebrandt | Apr 2002 | B1 |
6377548 | Chuah | Apr 2002 | B1 |
6388951 | Matsumoto et al. | May 2002 | B1 |
6406426 | Reuss et al. | Jun 2002 | B1 |
6408330 | de la Huerga | Jun 2002 | B1 |
6418334 | Unger et al. | Jul 2002 | B1 |
6427088 | Bowman et al. | Jul 2002 | B1 |
6428483 | Carlebach | Aug 2002 | B1 |
6442432 | Lee | Aug 2002 | B2 |
6469991 | Chuah | Oct 2002 | B1 |
6475180 | Peterson et al. | Nov 2002 | B2 |
6482158 | Mault | Nov 2002 | B2 |
6485418 | Yasushi et al. | Nov 2002 | B2 |
6494694 | Lawless et al. | Dec 2002 | B2 |
6494831 | Koritzinsky | Dec 2002 | B1 |
6497680 | Holst et al. | Dec 2002 | B1 |
6514460 | Fendrock | Feb 2003 | B1 |
6517482 | Eiden et al. | Feb 2003 | B1 |
6519569 | White et al. | Feb 2003 | B1 |
6520930 | Critchlow et al. | Feb 2003 | B2 |
6540672 | Simonsen et al. | Apr 2003 | B1 |
6542902 | Dulong et al. | Apr 2003 | B2 |
6544212 | Galley et al. | Apr 2003 | B2 |
6544228 | Heitmeier | Apr 2003 | B1 |
6546350 | Hartmann et al. | Apr 2003 | B1 |
6551276 | Mann et al. | Apr 2003 | B1 |
6554798 | Mann et al. | Apr 2003 | B1 |
6558320 | Causey et al. | May 2003 | B1 |
6558351 | Steil et al. | May 2003 | B1 |
6565509 | Say et al. | May 2003 | B1 |
6567416 | Chuah | May 2003 | B1 |
6571294 | Simmon et al. | May 2003 | B2 |
6572542 | Houben et al. | Jun 2003 | B1 |
6572545 | Knobbe et al. | Jun 2003 | B2 |
6578002 | Derzay et al. | Jun 2003 | B1 |
6581117 | Klein et al. | Jun 2003 | B1 |
6587034 | Heiman et al. | Jul 2003 | B1 |
6589229 | Connelly et al. | Jul 2003 | B1 |
6599281 | Struys et al. | Jul 2003 | B1 |
6602191 | Quy | Aug 2003 | B2 |
6605072 | Struys et al. | Aug 2003 | B2 |
6628809 | Rowe et al. | Sep 2003 | B1 |
6631353 | Davis et al. | Oct 2003 | B1 |
6640246 | Gardy, Jr. et al. | Oct 2003 | B1 |
6641533 | Causey, III et al. | Nov 2003 | B2 |
6647299 | Bourget | Nov 2003 | B2 |
6652455 | Kocher | Nov 2003 | B1 |
6653937 | Nelson et al. | Nov 2003 | B2 |
6659947 | Carter et al. | Dec 2003 | B1 |
6669630 | Joliat et al. | Dec 2003 | B1 |
6671563 | Engleson et al. | Dec 2003 | B1 |
6673033 | Sciulli et al. | Jan 2004 | B1 |
6674403 | Gray et al. | Jan 2004 | B2 |
6681003 | Linder et al. | Jan 2004 | B2 |
6689091 | Bui et al. | Feb 2004 | B2 |
6692241 | Watanabe et al. | Feb 2004 | B2 |
6694191 | Starkweather et al. | Feb 2004 | B2 |
6694334 | DuLong et al. | Feb 2004 | B2 |
6721286 | Williams et al. | Apr 2004 | B1 |
6721582 | Trepagnier et al. | Apr 2004 | B2 |
6725200 | Rost | Apr 2004 | B1 |
6731989 | Engleson et al. | May 2004 | B2 |
6740072 | Starkweather et al. | May 2004 | B2 |
6751651 | Crockett | Jun 2004 | B2 |
6752787 | Causey, III et al. | Jun 2004 | B1 |
6753830 | Gelbman | Jun 2004 | B2 |
6758810 | Lebel et al. | Jul 2004 | B2 |
6773396 | Flach et al. | Aug 2004 | B2 |
6774786 | Havekost et al. | Aug 2004 | B1 |
6775577 | Cmkovich et al. | Aug 2004 | B2 |
6780156 | Haueter et al. | Aug 2004 | B2 |
6790198 | White et al. | Sep 2004 | B1 |
6796956 | Hartlaub et al. | Sep 2004 | B2 |
6799149 | Hartlaub | Sep 2004 | B2 |
6809653 | Mann et al. | Oct 2004 | B1 |
6811534 | Bowman, IV et al. | Nov 2004 | B2 |
6816605 | Rowe et al. | Nov 2004 | B2 |
6839753 | Biondi et al. | Jan 2005 | B2 |
6852104 | Blomquist | Feb 2005 | B2 |
6859134 | Heiman et al. | Feb 2005 | B1 |
6871211 | Labounty et al. | Mar 2005 | B2 |
6873268 | Lebel et al. | Mar 2005 | B2 |
6876303 | Reeder et al. | Apr 2005 | B2 |
6885881 | Leonhardt | Apr 2005 | B2 |
6891525 | Ogoro | May 2005 | B2 |
6892278 | Ebergen | May 2005 | B2 |
6899695 | Herrera | May 2005 | B2 |
6915170 | Engleson et al. | Jul 2005 | B2 |
6923763 | Kovatchev et al. | Aug 2005 | B1 |
6924781 | Gelbman | Aug 2005 | B1 |
6928338 | Buchser et al. | Aug 2005 | B1 |
6936029 | Mann et al. | Aug 2005 | B2 |
6945954 | Hochman et al. | Sep 2005 | B2 |
6948492 | Wemeling et al. | Sep 2005 | B2 |
6958677 | Carter | Oct 2005 | B1 |
6958691 | Anderson et al. | Oct 2005 | B1 |
6958705 | Lebel et al. | Oct 2005 | B2 |
6961448 | Nichols et al. | Nov 2005 | B2 |
6969352 | Chiang et al. | Nov 2005 | B2 |
6969865 | Duchon et al. | Nov 2005 | B2 |
6974437 | Lebel et al. | Dec 2005 | B2 |
6979326 | Mann et al. | Dec 2005 | B2 |
6980958 | Surwit et al. | Dec 2005 | B1 |
6985870 | Martucci et al. | Jan 2006 | B2 |
6986347 | Hickle | Jan 2006 | B2 |
6997880 | Carlebach et al. | Feb 2006 | B2 |
6997920 | Mann et al. | Feb 2006 | B2 |
6998984 | Zittrain | Feb 2006 | B1 |
7017293 | Riley | Mar 2006 | B2 |
7025743 | Mann et al. | Apr 2006 | B2 |
7029455 | Flaherty | Apr 2006 | B2 |
7038584 | Carter | May 2006 | B2 |
7060031 | Webb et al. | Jun 2006 | B2 |
7060059 | Keith et al. | Jun 2006 | B2 |
7069552 | Lindberg et al. | Jun 2006 | B2 |
7072725 | Bristol et al. | Jul 2006 | B2 |
7079035 | Bock et al. | Jul 2006 | B2 |
7092943 | Roese et al. | Aug 2006 | B2 |
7096072 | Engleson et al. | Aug 2006 | B2 |
7099809 | Dori | Aug 2006 | B2 |
7103419 | Engleson et al. | Sep 2006 | B2 |
7103578 | Beck et al. | Sep 2006 | B2 |
7107106 | Engleson et al. | Sep 2006 | B2 |
7108680 | Rohr et al. | Sep 2006 | B2 |
7109878 | Mann et al. | Sep 2006 | B2 |
7117041 | Engleson et al. | Oct 2006 | B2 |
7136645 | Hanson et al. | Nov 2006 | B2 |
7137964 | Flaherty | Nov 2006 | B2 |
7142190 | Martinez | Nov 2006 | B2 |
7150741 | Erickson et al. | Dec 2006 | B2 |
7153289 | Vasko | Dec 2006 | B2 |
7154397 | Zerhusen et al. | Dec 2006 | B2 |
7156807 | Carter et al. | Jan 2007 | B2 |
7161484 | Tsoukalis et al. | Jan 2007 | B2 |
7167755 | Seeberger et al. | Jan 2007 | B2 |
7167920 | Traversat | Jan 2007 | B2 |
7171277 | Engleson et al. | Jan 2007 | B2 |
7171492 | Borella et al. | Jan 2007 | B1 |
7181493 | English et al. | Feb 2007 | B2 |
7185288 | McKeever | Feb 2007 | B2 |
7193514 | Ritson | Mar 2007 | B2 |
7197025 | Chuah | Mar 2007 | B2 |
7201734 | Hickle | Apr 2007 | B2 |
7204823 | Estes et al. | Apr 2007 | B2 |
7213009 | Pestotnik | May 2007 | B2 |
7216802 | de la Huerga | May 2007 | B1 |
7220240 | Struys et al. | May 2007 | B2 |
7224979 | Singhal et al. | May 2007 | B2 |
7229430 | Hickle et al. | Jun 2007 | B2 |
7230529 | Ketcherside | Jun 2007 | B2 |
7236936 | White et al. | Jun 2007 | B2 |
7238164 | Childers et al. | Jul 2007 | B2 |
7247154 | Hickle | Jul 2007 | B2 |
7248239 | Dowling | Jul 2007 | B2 |
7250856 | Havekost et al. | Jul 2007 | B2 |
7255683 | Vanderveen et al. | Aug 2007 | B2 |
7256888 | Staehr | Aug 2007 | B2 |
7258534 | Fathallah et al. | Aug 2007 | B2 |
7263213 | Rowe | Aug 2007 | B2 |
7267664 | Rizzo | Sep 2007 | B2 |
7267665 | Steil et al. | Sep 2007 | B2 |
7275156 | Balfanz et al. | Sep 2007 | B2 |
7278983 | Ireland et al. | Oct 2007 | B2 |
7289815 | Gfeller et al. | Oct 2007 | B2 |
7289948 | Mohri | Oct 2007 | B1 |
7293107 | Hanson et al. | Nov 2007 | B1 |
7295119 | Rappaport et al. | Nov 2007 | B2 |
7295556 | Roese et al. | Nov 2007 | B2 |
7301451 | Hastings | Nov 2007 | B2 |
7308300 | Toews et al. | Dec 2007 | B2 |
7315825 | Rosenfeld et al. | Jan 2008 | B2 |
7319386 | Collins, Jr. et al. | Jan 2008 | B2 |
7324000 | Zittrain et al. | Jan 2008 | B2 |
7327705 | Fletcher et al. | Feb 2008 | B2 |
7343224 | DiGianfilippo et al. | Mar 2008 | B2 |
7346025 | Bryson | Mar 2008 | B2 |
7347836 | Peterson et al. | Mar 2008 | B2 |
7354420 | Steil et al. | Apr 2008 | B2 |
7369897 | Boveja et al. | May 2008 | B2 |
7369948 | Ferenczi et al. | May 2008 | B1 |
7383088 | Spinelli et al. | Jun 2008 | B2 |
7384410 | Eggers et al. | Jun 2008 | B2 |
7398183 | Holland et al. | Jul 2008 | B2 |
7398279 | Muno, Jr. et al. | Jul 2008 | B2 |
7399277 | Saidara et al. | Jul 2008 | B2 |
7402153 | Steil et al. | Jul 2008 | B2 |
7420472 | Tran | Sep 2008 | B2 |
7432807 | Schmitt | Oct 2008 | B2 |
7447643 | Olson | Nov 2008 | B1 |
7454314 | Holland et al. | Nov 2008 | B2 |
7457804 | Uber, III et al. | Nov 2008 | B2 |
7464040 | Joao | Dec 2008 | B2 |
7471994 | Ford et al. | Dec 2008 | B2 |
7483756 | Engleson et al. | Jan 2009 | B2 |
7489808 | Gerder | Feb 2009 | B2 |
7490021 | Holland et al. | Feb 2009 | B2 |
7490048 | Joao | Feb 2009 | B2 |
7491187 | Van Den Berghe et al. | Feb 2009 | B2 |
7519905 | Kougiouris | Apr 2009 | B2 |
7523401 | Aldridge | Apr 2009 | B1 |
7524304 | Genosar | Apr 2009 | B2 |
7551078 | Carlson | Jun 2009 | B2 |
7559321 | Wermeling et al. | Jul 2009 | B2 |
7565197 | Haulbrich et al. | Jul 2009 | B2 |
7572230 | Neumann et al. | Aug 2009 | B2 |
7578802 | Hickle | Aug 2009 | B2 |
7621009 | Elhabashy | Nov 2009 | B2 |
D606533 | De Jong et al. | Dec 2009 | S |
7636718 | Steen et al. | Dec 2009 | B1 |
7640172 | Kuth | Dec 2009 | B2 |
7645258 | White et al. | Jan 2010 | B2 |
7647237 | Malave et al. | Jan 2010 | B2 |
7662124 | Duchon et al. | Feb 2010 | B2 |
7668731 | Martucci et al. | Feb 2010 | B2 |
7671733 | McNeal et al. | Mar 2010 | B2 |
7678071 | Lebel et al. | Mar 2010 | B2 |
7687678 | Jacobs | Mar 2010 | B2 |
7697994 | VanDanacker et al. | Apr 2010 | B2 |
7698239 | Lieuallen | Apr 2010 | B2 |
7705727 | Pestotnik | Apr 2010 | B2 |
7724147 | Brown et al. | May 2010 | B2 |
7739126 | Cave | Jun 2010 | B1 |
7746218 | Collins, Jr. | Jun 2010 | B2 |
7766873 | Moberg et al. | Aug 2010 | B2 |
7776029 | Whitehurst et al. | Aug 2010 | B2 |
7776031 | Hartlaub et al. | Aug 2010 | B2 |
7785313 | Mastrototaro | Aug 2010 | B2 |
7806852 | Jurson | Oct 2010 | B1 |
7806886 | Kanderian, Jr. et al. | Oct 2010 | B2 |
7826981 | Goode, Jr. et al. | Nov 2010 | B2 |
7835927 | Schlotterbeck et al. | Nov 2010 | B2 |
7836314 | Chieu | Nov 2010 | B2 |
7856276 | Ripart et al. | Dec 2010 | B2 |
7860583 | Condurso et al. | Dec 2010 | B2 |
7868754 | Salvat, Jr. | Jan 2011 | B2 |
7871394 | Halbert et al. | Jan 2011 | B2 |
7886231 | Hopermann et al. | Feb 2011 | B2 |
7895053 | Holland et al. | Feb 2011 | B2 |
7896842 | Palmroos et al. | Mar 2011 | B2 |
7899546 | Sieracki et al. | Mar 2011 | B2 |
7905710 | Wang et al. | Mar 2011 | B2 |
7920061 | Klein et al. | Apr 2011 | B2 |
7933780 | de la Huerga | Apr 2011 | B2 |
7938796 | Moubayed | May 2011 | B2 |
7945452 | Fathallah et al. | May 2011 | B2 |
7974714 | Hoffberg | Jul 2011 | B2 |
7996241 | Zak | Aug 2011 | B2 |
8034026 | Grant | Oct 2011 | B2 |
8038593 | Friedman et al. | Oct 2011 | B2 |
8048040 | Kiani | Nov 2011 | B2 |
8060576 | Chan et al. | Nov 2011 | B2 |
8065161 | Howard et al. | Nov 2011 | B2 |
8066672 | Mandro | Nov 2011 | B2 |
8078983 | Davis et al. | Dec 2011 | B2 |
8082018 | Duchon et al. | Dec 2011 | B2 |
8082312 | Chan et al. | Dec 2011 | B2 |
8147448 | Sundar et al. | Apr 2012 | B2 |
8149131 | Blornquist | Apr 2012 | B2 |
8169914 | Bajpai | May 2012 | B2 |
8171094 | Chan et al. | May 2012 | B2 |
8172798 | Hungerford et al. | May 2012 | B2 |
8185322 | Schroeder et al. | May 2012 | B2 |
8195478 | Petersen et al. | Jun 2012 | B2 |
8206350 | Mann et al. | Jun 2012 | B2 |
8219413 | Martinez et al. | Jul 2012 | B2 |
8231578 | Fathallah et al. | Jul 2012 | B2 |
8234128 | Martucci et al. | Jul 2012 | B2 |
8267892 | Spencer et al. | Sep 2012 | B2 |
8271106 | Wehba et al. | Sep 2012 | B2 |
8287495 | Michaud et al. | Oct 2012 | B2 |
8291337 | Gannin et al. | Oct 2012 | B2 |
8298184 | DiPerna et al. | Oct 2012 | B2 |
8352290 | Bartz et al. | Jan 2013 | B2 |
8359338 | Butterfield et al. | Jan 2013 | B2 |
8380536 | Howard et al. | Feb 2013 | B2 |
8387112 | Ranjan et al. | Feb 2013 | B1 |
8394077 | Jacobson et al. | Mar 2013 | B2 |
8403908 | Jacobson et al. | Mar 2013 | B2 |
8435206 | Evans et al. | May 2013 | B2 |
8449523 | Brukalo et al. | May 2013 | B2 |
8452953 | Buck et al. | May 2013 | B2 |
8453645 | Figueiredo et al. | Jun 2013 | B2 |
8480648 | Burnett et al. | Jul 2013 | B2 |
8489427 | Simpson | Jul 2013 | B2 |
8494879 | Davis et al. | Jul 2013 | B2 |
8504179 | Blomquist | Aug 2013 | B2 |
8517990 | Teel et al. | Aug 2013 | B2 |
8518021 | Stewart et al. | Aug 2013 | B2 |
8543416 | Palmroos et al. | Sep 2013 | B2 |
8551038 | Tsoukalis et al. | Oct 2013 | B2 |
8560345 | Wehba et al. | Oct 2013 | B2 |
8577692 | Silkaitis et al. | Nov 2013 | B2 |
8579884 | Lanier et al. | Nov 2013 | B2 |
8626530 | Tran et al. | Jan 2014 | B1 |
8655676 | Wehba et al. | Feb 2014 | B2 |
8660860 | Wehba et al. | Feb 2014 | B2 |
8662388 | Belkin | Mar 2014 | B2 |
8666769 | Butler et al. | Mar 2014 | B2 |
8700421 | Feng et al. | Apr 2014 | B2 |
8731960 | Butler et al. | May 2014 | B2 |
8768719 | Wehba et al. | Jul 2014 | B2 |
8771251 | Ruchti et al. | Jul 2014 | B2 |
8777894 | Butterfield et al. | Jul 2014 | B2 |
8777895 | Hsu et al. | Jul 2014 | B2 |
8799012 | Butler et al. | Aug 2014 | B2 |
8876793 | Ledford et al. | Nov 2014 | B2 |
8922330 | Moberg et al. | Dec 2014 | B2 |
8936565 | Chawla | Jan 2015 | B2 |
8952794 | Bloomquist et al. | Feb 2015 | B2 |
8998100 | Halbert et al. | Apr 2015 | B2 |
9026370 | Rubalcaba et al. | May 2015 | B2 |
9069887 | Gupta et al. | Jun 2015 | B2 |
9089642 | Murphy et al. | Jul 2015 | B2 |
9114217 | Sur et al. | Aug 2015 | B2 |
9123077 | Silkaitis et al. | Sep 2015 | B2 |
9192712 | DeBelser et al. | Nov 2015 | B2 |
9240002 | Hume et al. | Jan 2016 | B2 |
9381296 | Arrizza et al. | Jul 2016 | B2 |
9393362 | Cozmi et al. | Jul 2016 | B2 |
9498583 | Sur et al. | Nov 2016 | B2 |
9539383 | Kohlbrecher | Jan 2017 | B2 |
9572923 | Howard et al. | Feb 2017 | B2 |
9594875 | Arrizza et al. | Mar 2017 | B2 |
9604000 | Wehba et al. | Mar 2017 | B2 |
9641432 | Jha et al. | May 2017 | B2 |
9649431 | Gray et al. | May 2017 | B2 |
9662436 | Belkin et al. | May 2017 | B2 |
9690909 | Stewart et al. | Jun 2017 | B2 |
9707341 | Dumas, III et al. | Jul 2017 | B2 |
9724470 | Day et al. | Aug 2017 | B2 |
9764082 | Day et al. | Sep 2017 | B2 |
9971871 | Arrizza et al. | May 2018 | B2 |
9995611 | Ruchti et al. | Jun 2018 | B2 |
10022498 | Ruchti et al. | Jul 2018 | B2 |
10042986 | Ruchti et al. | Aug 2018 | B2 |
10046112 | Oruklu et al. | Aug 2018 | B2 |
10166328 | Oruklu et al. | Jan 2019 | B2 |
10238799 | Kohlbrecher | Mar 2019 | B2 |
10238801 | Wehba et al. | Mar 2019 | B2 |
10242060 | Butler et al. | Mar 2019 | B2 |
10300194 | Day et al. | May 2019 | B2 |
10311972 | Kohlbrecher et al. | Jun 2019 | B2 |
10314974 | Day et al. | Jun 2019 | B2 |
10333843 | Jha et al. | Jun 2019 | B2 |
10430761 | Hume et al. | Oct 2019 | B2 |
10434246 | Silkaitis et al. | Oct 2019 | B2 |
10463788 | Day | Nov 2019 | B2 |
20010016056 | Westphal et al. | Aug 2001 | A1 |
20010031944 | Peterson et al. | Oct 2001 | A1 |
20010032099 | Joao | Oct 2001 | A1 |
20010037060 | Thompson et al. | Nov 2001 | A1 |
20010044731 | Coffman et al. | Nov 2001 | A1 |
20010048027 | Walsh | Dec 2001 | A1 |
20010051787 | Haller et al. | Dec 2001 | A1 |
20010056358 | Dulong et al. | Dec 2001 | A1 |
20020010595 | Kapp | Jan 2002 | A1 |
20020013551 | Zaitsu | Jan 2002 | A1 |
20020013723 | Mise | Jan 2002 | A1 |
20020015018 | Shimazu et al. | Feb 2002 | A1 |
20020019584 | Schulze et al. | Feb 2002 | A1 |
20020026103 | Norris et al. | Feb 2002 | A1 |
20020029776 | Blomquist | Mar 2002 | A1 |
20020032583 | Joao | Mar 2002 | A1 |
20020038392 | de la Huerga | Mar 2002 | A1 |
20020040208 | Flaherty et al. | Apr 2002 | A1 |
20020040282 | Bailey et al. | Apr 2002 | A1 |
20020082728 | Mueller et al. | Jun 2002 | A1 |
20020087115 | Hartlaub | Jul 2002 | A1 |
20020087116 | Hartlaub | Jul 2002 | A1 |
20020095486 | Bahl | Jul 2002 | A1 |
20020103675 | Vanelli | Aug 2002 | A1 |
20020123905 | Goodroe et al. | Sep 2002 | A1 |
20020143580 | Bristol et al. | Oct 2002 | A1 |
20020152239 | Bautista-Lloyd et al. | Oct 2002 | A1 |
20020169636 | Eggers et al. | Nov 2002 | A1 |
20020173702 | Lebel et al. | Nov 2002 | A1 |
20020173875 | Wallace et al. | Nov 2002 | A1 |
20020194329 | Alling | Dec 2002 | A1 |
20030009244 | Engleson | Jan 2003 | A1 |
20030013959 | Grunwald et al. | Jan 2003 | A1 |
20030014222 | Klass et al. | Jan 2003 | A1 |
20030014817 | Gallant et al. | Jan 2003 | A1 |
20030025602 | Medema et al. | Feb 2003 | A1 |
20030028082 | Thompson | Feb 2003 | A1 |
20030036683 | Kehr et al. | Feb 2003 | A1 |
20030047126 | Tomaschko | Mar 2003 | A1 |
20030050621 | Lebel et al. | Mar 2003 | A1 |
20030059750 | Bindler et al. | Mar 2003 | A1 |
20030060688 | Ciarniello et al. | Mar 2003 | A1 |
20030069963 | Jayant et al. | Apr 2003 | A1 |
20030079746 | Hickle | May 2003 | A1 |
20030097529 | Arimilli et al. | May 2003 | A1 |
20030104982 | Wittmann et al. | Jun 2003 | A1 |
20030106553 | Vanderveen | Jun 2003 | A1 |
20030115358 | Yun | Jun 2003 | A1 |
20030120384 | Haitin et al. | Jun 2003 | A1 |
20030125662 | Bui | Jul 2003 | A1 |
20030130616 | Steil | Jul 2003 | A1 |
20030135087 | Hickle et al. | Jul 2003 | A1 |
20030139701 | White et al. | Jul 2003 | A1 |
20030140928 | Bui et al. | Jul 2003 | A1 |
20030140929 | Wilkes et al. | Jul 2003 | A1 |
20030141981 | Bui et al. | Jul 2003 | A1 |
20030143746 | Sage, Jr. | Jul 2003 | A1 |
20030144878 | Wilkes et al. | Jul 2003 | A1 |
20030158749 | Olchanski et al. | Aug 2003 | A1 |
20030187338 | Say et al. | Oct 2003 | A1 |
20030200116 | Forrester | Oct 2003 | A1 |
20030204416 | Acharya | Oct 2003 | A1 |
20030204781 | Peebles et al. | Oct 2003 | A1 |
20030212364 | Mann et al. | Nov 2003 | A1 |
20030212379 | Bylund et al. | Nov 2003 | A1 |
20030212821 | Gillies et al. | Nov 2003 | A1 |
20030217962 | Childers et al. | Nov 2003 | A1 |
20040015132 | Brown | Jan 2004 | A1 |
20040019607 | Moubayed et al. | Jan 2004 | A1 |
20040030323 | Ullestad et al. | Feb 2004 | A1 |
20040039257 | Hickle | Feb 2004 | A1 |
20040057226 | Berthou et al. | Mar 2004 | A1 |
20040064341 | Langan et al. | Apr 2004 | A1 |
20040064342 | Browne et al. | Apr 2004 | A1 |
20040064435 | Moubayed et al. | Apr 2004 | A1 |
20040073811 | Sanin | Apr 2004 | A1 |
20040077934 | Massad | Apr 2004 | A1 |
20040078231 | Wilkes et al. | Apr 2004 | A1 |
20040078236 | Stoodley et al. | Apr 2004 | A1 |
20040104271 | Martucci et al. | Jun 2004 | A1 |
20040122530 | Hansen | Jun 2004 | A1 |
20040128162 | Schlotterbeck et al. | Jul 2004 | A1 |
20040128163 | Goodman et al. | Jul 2004 | A1 |
20040133441 | Brady et al. | Jul 2004 | A1 |
20040139004 | Cohen et al. | Jul 2004 | A1 |
20040145480 | Despotis | Jul 2004 | A1 |
20040147034 | Gore et al. | Jul 2004 | A1 |
20040167464 | Ireland et al. | Aug 2004 | A1 |
20040167465 | Kohler | Aug 2004 | A1 |
20040167804 | Simpson | Aug 2004 | A1 |
20040172222 | Simpson et al. | Sep 2004 | A1 |
20040172283 | Vanderveen | Sep 2004 | A1 |
20040172301 | Mihai et al. | Sep 2004 | A1 |
20040172302 | Martucci et al. | Sep 2004 | A1 |
20040176667 | Mihai et al. | Sep 2004 | A1 |
20040176980 | Bulitta et al. | Sep 2004 | A1 |
20040176984 | White et al. | Sep 2004 | A1 |
20040181314 | Zaleski | Sep 2004 | A1 |
20040189708 | Larcheveque et al. | Sep 2004 | A1 |
20040193325 | Bonderud | Sep 2004 | A1 |
20040193328 | Butterfield et al. | Sep 2004 | A1 |
20040193453 | Butterfield et al. | Sep 2004 | A1 |
20040204673 | Flaherty et al. | Oct 2004 | A1 |
20040215278 | Stegink et al. | Oct 2004 | A1 |
20040220517 | Starkweather et al. | Nov 2004 | A1 |
20040225252 | Gillespie et al. | Nov 2004 | A1 |
20040236240 | Kraus et al. | Nov 2004 | A1 |
20040243438 | Mintz | Dec 2004 | A1 |
20040254434 | Goodnow et al. | Dec 2004 | A1 |
20050010269 | Lebel et al. | Jan 2005 | A1 |
20050020886 | Hutchinson et al. | Jan 2005 | A1 |
20050021006 | Tonnies | Jan 2005 | A1 |
20050027560 | Cook | Feb 2005 | A1 |
20050027567 | Taha | Feb 2005 | A1 |
20050038311 | Kuth | Feb 2005 | A1 |
20050038669 | Sachdeva et al. | Feb 2005 | A1 |
20050038680 | McMahon | Feb 2005 | A1 |
20050040226 | Al-Sheikh | Feb 2005 | A1 |
20050043620 | Fallows et al. | Feb 2005 | A1 |
20050049910 | Lancaster et al. | Mar 2005 | A1 |
20050055242 | Bello et al. | Mar 2005 | A1 |
20050055244 | Mullan et al. | Mar 2005 | A1 |
20050065465 | Lebel et al. | Mar 2005 | A1 |
20050065817 | Mihai et al. | Mar 2005 | A1 |
20050075544 | Shapiro et al. | Apr 2005 | A1 |
20050080801 | Kothandaraman et al. | Apr 2005 | A1 |
20050086071 | Fox, Jr. et al. | Apr 2005 | A1 |
20050086072 | Fox | Apr 2005 | A1 |
20050090808 | Malave et al. | Apr 2005 | A1 |
20050099624 | Staehr | May 2005 | A1 |
20050102162 | Blumenfeld | May 2005 | A1 |
20050102165 | Oshita et al. | May 2005 | A1 |
20050102167 | Kapoor | May 2005 | A1 |
20050102669 | Marney et al. | May 2005 | A1 |
20050107923 | Vanderveen | May 2005 | A1 |
20050108057 | Cohen | May 2005 | A1 |
20050117529 | Ramos-Escano | Jun 2005 | A1 |
20050119788 | Engleson et al. | Jun 2005 | A1 |
20050119914 | Batch | Jun 2005 | A1 |
20050131739 | Rabinowitz et al. | Jun 2005 | A1 |
20050137522 | Aoki | Jun 2005 | A1 |
20050137573 | McLaughlin | Jun 2005 | A1 |
20050154769 | Eckart et al. | Jul 2005 | A1 |
20050160057 | Wefers et al. | Jul 2005 | A1 |
20050171503 | Van Den Berghe et al. | Aug 2005 | A1 |
20050171815 | Vanderveen | Aug 2005 | A1 |
20050177096 | Bollish et al. | Aug 2005 | A1 |
20050177395 | Blomquist | Aug 2005 | A1 |
20050182306 | Sloan | Aug 2005 | A1 |
20050182355 | Bui | Aug 2005 | A1 |
20050187950 | Parker | Aug 2005 | A1 |
20050192557 | Brauker et al. | Sep 2005 | A1 |
20050197554 | Polcha | Sep 2005 | A1 |
20050197621 | Poulsen et al. | Sep 2005 | A1 |
20050210037 | Wefers et al. | Sep 2005 | A1 |
20050216479 | Wefers et al. | Sep 2005 | A1 |
20050216480 | Wefers et al. | Sep 2005 | A1 |
20050223045 | Funahashi et al. | Oct 2005 | A1 |
20050224083 | Crass | Oct 2005 | A1 |
20050234746 | Funahashi | Oct 2005 | A1 |
20050240305 | Bogash et al. | Oct 2005 | A1 |
20050246416 | Blomquist | Nov 2005 | A1 |
20050251418 | Fox, Jr. et al. | Nov 2005 | A1 |
20050273059 | Mernoe et al. | Dec 2005 | A1 |
20050277873 | Stewart et al. | Dec 2005 | A1 |
20050277890 | Stewart et al. | Dec 2005 | A1 |
20050277911 | Stewart et al. | Dec 2005 | A1 |
20050278194 | Holland et al. | Dec 2005 | A1 |
20060004772 | Hagan et al. | Jan 2006 | A1 |
20060009727 | O'Mahony et al. | Jan 2006 | A1 |
20060009734 | Martin | Jan 2006 | A1 |
20060010098 | Goodnow et al. | Jan 2006 | A1 |
20060042139 | Mendes | Mar 2006 | A1 |
20060047270 | Shelton | Mar 2006 | A1 |
20060053036 | Coffman et al. | Mar 2006 | A1 |
20060064020 | Burnes et al. | Mar 2006 | A1 |
20060074633 | Mahesh et al. | Apr 2006 | A1 |
20060074920 | Wefers et al. | Apr 2006 | A1 |
20060079831 | Gilbert | Apr 2006 | A1 |
20060089854 | Holland et al. | Apr 2006 | A1 |
20060089855 | Holland et al. | Apr 2006 | A1 |
20060100746 | Leibner-Druska | May 2006 | A1 |
20060100907 | Holland et al. | May 2006 | A1 |
20060106649 | Eggers et al. | May 2006 | A1 |
20060111943 | Wu | May 2006 | A1 |
20060116904 | Brem | Jun 2006 | A1 |
20060116907 | Rhodes et al. | Jun 2006 | A1 |
20060122481 | Sievenpiper et al. | Jun 2006 | A1 |
20060122867 | Eggers et al. | Jun 2006 | A1 |
20060129429 | Moubayed et al. | Jun 2006 | A1 |
20060129434 | Smitherman et al. | Jun 2006 | A1 |
20060129435 | Smitherman et al. | Jun 2006 | A1 |
20060136266 | Tarassenko et al. | Jun 2006 | A1 |
20060136271 | Eggers et al. | Jun 2006 | A1 |
20060143051 | Eggers et al. | Jun 2006 | A1 |
20060173260 | Gaoni et al. | Aug 2006 | A1 |
20060173406 | Hayes et al. | Aug 2006 | A1 |
20060173715 | Wang et al. | Aug 2006 | A1 |
20060173927 | Beyer et al. | Aug 2006 | A1 |
20060190302 | Eggers et al. | Aug 2006 | A1 |
20060195022 | Trepagnier et al. | Aug 2006 | A1 |
20060200007 | Brockway et al. | Sep 2006 | A1 |
20060200369 | Batch et al. | Sep 2006 | A1 |
20060211404 | Cromp et al. | Sep 2006 | A1 |
20060224141 | Rush et al. | Oct 2006 | A1 |
20060229918 | Fotsch et al. | Oct 2006 | A1 |
20060258985 | Russell | Nov 2006 | A1 |
20060259327 | Hoag | Nov 2006 | A1 |
20060264895 | Flanders | Nov 2006 | A1 |
20060265246 | Hoag | Nov 2006 | A1 |
20060267753 | Hussey et al. | Nov 2006 | A1 |
20060268710 | Appanna et al. | Nov 2006 | A1 |
20060277206 | Bailey et al. | Dec 2006 | A1 |
20060287885 | Frick | Dec 2006 | A1 |
20070015972 | Wang et al. | Jan 2007 | A1 |
20070016443 | Wachman et al. | Jan 2007 | A1 |
20070027506 | Stender et al. | Feb 2007 | A1 |
20070060796 | Kim | Mar 2007 | A1 |
20070060870 | Tolle et al. | Mar 2007 | A1 |
20070060871 | Istoc | Mar 2007 | A1 |
20070061393 | Moore | Mar 2007 | A1 |
20070065363 | Dalal et al. | Mar 2007 | A1 |
20070073419 | Sesay | Mar 2007 | A1 |
20070078314 | Grounsell | Apr 2007 | A1 |
20070083870 | Kanakogi | Apr 2007 | A1 |
20070088333 | Levin et al. | Apr 2007 | A1 |
20070093786 | Goldsmith et al. | Apr 2007 | A1 |
20070100665 | Brown | May 2007 | A1 |
20070100667 | Bardy | May 2007 | A1 |
20070106126 | Mannheimer et al. | May 2007 | A1 |
20070112298 | Mueller et al. | May 2007 | A1 |
20070116037 | Moore | May 2007 | A1 |
20070118405 | Campbell et al. | May 2007 | A1 |
20070135866 | Baker | Jun 2007 | A1 |
20070136098 | Smythe et al. | Jun 2007 | A1 |
20070142822 | Remde | Jun 2007 | A1 |
20070156282 | Dunn | Jul 2007 | A1 |
20070156452 | Batch | Jul 2007 | A1 |
20070169008 | Varanasi et al. | Jul 2007 | A1 |
20070179448 | Lim et al. | Aug 2007 | A1 |
20070186923 | Poutiatine et al. | Aug 2007 | A1 |
20070191817 | Martin | Aug 2007 | A1 |
20070191973 | Holzbauer et al. | Aug 2007 | A1 |
20070213657 | Jennewine et al. | Sep 2007 | A1 |
20070214003 | Holland et al. | Sep 2007 | A1 |
20070215545 | Bissler et al. | Sep 2007 | A1 |
20070232867 | Hansmann | Oct 2007 | A1 |
20070233035 | Wehba et al. | Oct 2007 | A1 |
20070233049 | Wehba et al. | Oct 2007 | A1 |
20070233206 | Frikart | Oct 2007 | A1 |
20070233520 | Wehba et al. | Oct 2007 | A1 |
20070251835 | Mehta et al. | Nov 2007 | A1 |
20070253021 | Mehta et al. | Nov 2007 | A1 |
20070254593 | Jollota et al. | Nov 2007 | A1 |
20070255125 | Moberg et al. | Nov 2007 | A1 |
20070257788 | Carlson | Nov 2007 | A1 |
20070258395 | Jollota et al. | Nov 2007 | A1 |
20070299687 | Palmer et al. | Dec 2007 | A1 |
20070299695 | Jung et al. | Dec 2007 | A1 |
20080004904 | Tran | Jan 2008 | A1 |
20080009684 | Corsetti et al. | Jan 2008 | A1 |
20080033361 | Evans et al. | Feb 2008 | A1 |
20080034323 | Blomquist | Feb 2008 | A1 |
20080041942 | Aissa | Feb 2008 | A1 |
20080052704 | Wysocki | Feb 2008 | A1 |
20080065007 | Peterson et al. | Mar 2008 | A1 |
20080065417 | Jung et al. | Mar 2008 | A1 |
20080071217 | Moubayed et al. | Mar 2008 | A1 |
20080071251 | Moubayed et al. | Mar 2008 | A1 |
20080091466 | Butler et al. | Apr 2008 | A1 |
20080095339 | Elliott | Apr 2008 | A1 |
20080097289 | Steil et al. | Apr 2008 | A1 |
20080126969 | Blomquist | May 2008 | A1 |
20080139907 | Rao et al. | Jun 2008 | A1 |
20080149117 | Raghuram | Jun 2008 | A1 |
20080154177 | Moubayed et al. | Jun 2008 | A1 |
20080172337 | Banfield et al. | Jul 2008 | A1 |
20080184219 | Matsumoto | Jul 2008 | A1 |
20080188796 | Steil et al. | Aug 2008 | A1 |
20080214919 | Harmon et al. | Sep 2008 | A1 |
20080246748 | Cassidy et al. | Oct 2008 | A1 |
20080256305 | Kwon | Oct 2008 | A1 |
20080262469 | Bristol et al. | Oct 2008 | A1 |
20080269714 | Mastrototaro et al. | Oct 2008 | A1 |
20080269723 | Mastrototaro et al. | Oct 2008 | A1 |
20080275384 | Mastrototaro et al. | Nov 2008 | A1 |
20080300572 | Rankers et al. | Dec 2008 | A1 |
20080320387 | Sasaki et al. | Dec 2008 | A1 |
20080320466 | Dias | Dec 2008 | A1 |
20090005703 | Fasciano | Jan 2009 | A1 |
20090005728 | Weinert et al. | Jan 2009 | A1 |
20090006061 | Thukral et al. | Jan 2009 | A1 |
20090006129 | Thukral | Jan 2009 | A1 |
20090006133 | Weinert | Jan 2009 | A1 |
20090018495 | Panduro | Jan 2009 | A1 |
20090051560 | Manning et al. | Feb 2009 | A1 |
20090054743 | Stewart | Feb 2009 | A1 |
20090054754 | McMahon et al. | Feb 2009 | A1 |
20090057399 | Sajkowsky | Mar 2009 | A1 |
20090069785 | Miller et al. | Mar 2009 | A1 |
20090099867 | Newman | Apr 2009 | A1 |
20090135196 | Holland et al. | May 2009 | A1 |
20090143662 | Estes et al. | Jun 2009 | A1 |
20090149743 | Barron et al. | Jun 2009 | A1 |
20090150174 | Buck et al. | Jun 2009 | A1 |
20090150878 | Pathak et al. | Jun 2009 | A1 |
20090156991 | Roberts | Jun 2009 | A1 |
20090157695 | Roberts | Jun 2009 | A1 |
20090158274 | Roberts | Jun 2009 | A1 |
20090177146 | Nesbitt et al. | Jul 2009 | A1 |
20090177769 | Roberts | Jul 2009 | A1 |
20090177992 | Rubalcaba et al. | Jul 2009 | A1 |
20090183147 | Davis et al. | Jul 2009 | A1 |
20090209938 | Aalto-Setala | Aug 2009 | A1 |
20090210250 | Prax et al. | Aug 2009 | A1 |
20090221890 | Saffer et al. | Sep 2009 | A1 |
20090231249 | Wang et al. | Sep 2009 | A1 |
20090270833 | DeBelser | Oct 2009 | A1 |
20090275886 | Bloomquist et al. | Nov 2009 | A1 |
20090275896 | Kamen et al. | Nov 2009 | A1 |
20090284691 | Marhefka et al. | Nov 2009 | A1 |
20090326340 | Wang | Dec 2009 | A1 |
20090326516 | Bangera et al. | Dec 2009 | A1 |
20100022988 | Wochner | Jan 2010 | A1 |
20100036310 | Hillman | Feb 2010 | A1 |
20100056992 | Hayter | Mar 2010 | A1 |
20100095229 | Dixon et al. | Apr 2010 | A1 |
20100121170 | Rule | May 2010 | A1 |
20100121415 | Skelton et al. | May 2010 | A1 |
20100121654 | Portnoy et al. | May 2010 | A1 |
20100121752 | Banigan et al. | May 2010 | A1 |
20100130933 | Holland et al. | May 2010 | A1 |
20100131434 | Magent et al. | May 2010 | A1 |
20100138523 | Umess et al. | Jun 2010 | A1 |
20100146137 | Wu et al. | Jun 2010 | A1 |
20100156633 | Buck et al. | Jun 2010 | A1 |
20100160854 | Gauthier | Jun 2010 | A1 |
20100160860 | Celentano et al. | Jun 2010 | A1 |
20100174266 | Estes | Jul 2010 | A1 |
20100191525 | Rabenko et al. | Jul 2010 | A1 |
20100198034 | Thomas et al. | Aug 2010 | A1 |
20100198196 | Wei | Aug 2010 | A1 |
20100200506 | Ware et al. | Aug 2010 | A1 |
20100209268 | Davis | Aug 2010 | A1 |
20100212675 | Walling et al. | Aug 2010 | A1 |
20100217621 | Schoenberg | Aug 2010 | A1 |
20100234708 | Buck et al. | Sep 2010 | A1 |
20100250732 | Bucknell | Sep 2010 | A1 |
20100271479 | Heydlauf | Oct 2010 | A1 |
20100273738 | Valcke et al. | Oct 2010 | A1 |
20100280486 | Khair et al. | Nov 2010 | A1 |
20100292634 | Kircher | Nov 2010 | A1 |
20100298765 | Budiman et al. | Nov 2010 | A1 |
20100318025 | John | Dec 2010 | A1 |
20110001605 | Kiani et al. | Jan 2011 | A1 |
20110040158 | Katz et al. | Feb 2011 | A1 |
20110060758 | Schlotterbeck et al. | Mar 2011 | A1 |
20110071844 | Cannon et al. | Mar 2011 | A1 |
20110072379 | Gannon | Mar 2011 | A1 |
20110078608 | Gannon et al. | Mar 2011 | A1 |
20110093284 | Dicks et al. | Apr 2011 | A1 |
20110099313 | Bolanowski | Apr 2011 | A1 |
20110125095 | Lebel et al. | May 2011 | A1 |
20110138185 | Ju et al. | Jun 2011 | A1 |
20110175728 | Baker, Jr. | Jul 2011 | A1 |
20110178462 | Moberg et al. | Jul 2011 | A1 |
20110196748 | Caron et al. | Aug 2011 | A1 |
20110231216 | Fyke et al. | Sep 2011 | A1 |
20110257496 | Terashima et al. | Oct 2011 | A1 |
20110257798 | Ali et al. | Oct 2011 | A1 |
20110259954 | Bartz et al. | Oct 2011 | A1 |
20110264043 | Kotnick et al. | Oct 2011 | A1 |
20110264044 | Bartz et al. | Oct 2011 | A1 |
20110266221 | Ware et al. | Nov 2011 | A1 |
20110270045 | Lebel et al. | Nov 2011 | A1 |
20110275904 | Lebel et al. | Nov 2011 | A1 |
20110286457 | Ee | Nov 2011 | A1 |
20110289497 | Kiaie et al. | Nov 2011 | A1 |
20110295196 | Chazot et al. | Dec 2011 | A1 |
20110295341 | Estes et al. | Dec 2011 | A1 |
20110296051 | Vange | Dec 2011 | A1 |
20110296411 | Tang et al. | Dec 2011 | A1 |
20110313789 | Karmen et al. | Dec 2011 | A1 |
20110319813 | Kamen et al. | Dec 2011 | A1 |
20110320049 | Chossat et al. | Dec 2011 | A1 |
20120005680 | Dolby et al. | Jan 2012 | A1 |
20120011253 | Friedman et al. | Jan 2012 | A1 |
20120016305 | Jollota | Jan 2012 | A1 |
20120029941 | Malave et al. | Feb 2012 | A1 |
20120070045 | Vesper et al. | Mar 2012 | A1 |
20120095437 | Hemmerling | Apr 2012 | A1 |
20120112903 | Kaib et al. | May 2012 | A1 |
20120130198 | Beaule | May 2012 | A1 |
20120143116 | Ware et al. | Jun 2012 | A1 |
20120150556 | Galasso et al. | Jun 2012 | A1 |
20120157920 | Flachbart et al. | Jun 2012 | A1 |
20120179135 | Rinehart et al. | Jul 2012 | A1 |
20120179136 | Rinehart et al. | Jul 2012 | A1 |
20120203177 | Lanier | Aug 2012 | A1 |
20120245554 | Kawamura | Sep 2012 | A1 |
20120259978 | Petersen et al. | Oct 2012 | A1 |
20120277716 | Ali et al. | Nov 2012 | A1 |
20120284734 | McQuaid et al. | Nov 2012 | A1 |
20120323212 | Murphy | Dec 2012 | A1 |
20130006666 | Schneider | Jan 2013 | A1 |
20130006702 | Wu | Jan 2013 | A1 |
20130012877 | Debelser et al. | Jan 2013 | A1 |
20130012880 | Blomquist | Jan 2013 | A1 |
20130015980 | Evans et al. | Jan 2013 | A1 |
20130036403 | Geist | Feb 2013 | A1 |
20130036412 | Birtwhistle et al. | Feb 2013 | A1 |
20130066265 | Grant | Mar 2013 | A1 |
20130072872 | Yodfat et al. | Mar 2013 | A1 |
20130096444 | Condurso et al. | Apr 2013 | A1 |
20130096648 | Benson | Apr 2013 | A1 |
20130102963 | Marsh et al. | Apr 2013 | A1 |
20130138452 | Cork et al. | May 2013 | A1 |
20130144206 | Lee et al. | Jun 2013 | A1 |
20130167245 | Birtwhistle et al. | Jun 2013 | A1 |
20130191770 | Bartz et al. | Jul 2013 | A1 |
20130204188 | Kamen et al. | Aug 2013 | A1 |
20130218080 | Peterfreund et al. | Aug 2013 | A1 |
20130274669 | Stempfle et al. | Oct 2013 | A1 |
20130275539 | Gross et al. | Oct 2013 | A1 |
20130291116 | Homer | Oct 2013 | A1 |
20130296823 | Melker et al. | Nov 2013 | A1 |
20130296984 | Burnett et al. | Nov 2013 | A1 |
20130317753 | Kamen et al. | Nov 2013 | A1 |
20130346108 | Kamen et al. | Dec 2013 | A1 |
20140039446 | Day | Feb 2014 | A1 |
20140163517 | Finan et al. | Jun 2014 | A1 |
20140180711 | Kamen et al. | Jun 2014 | A1 |
20140257251 | Bush et al. | Sep 2014 | A1 |
20140266790 | Al-Ali et al. | Sep 2014 | A1 |
20140269643 | Sun | Sep 2014 | A1 |
20140288947 | Simpson et al. | Sep 2014 | A1 |
20140297329 | Rock | Oct 2014 | A1 |
20140366878 | Baron | Dec 2014 | A1 |
20150005935 | Bae et al. | Jan 2015 | A1 |
20150066531 | Jacobson et al. | Mar 2015 | A1 |
20150100038 | McCann et al. | Apr 2015 | A1 |
20150134265 | Kohlbrecher et al. | May 2015 | A1 |
20150151051 | Tsoukalis | Jun 2015 | A1 |
20150379237 | Mills et al. | Dec 2015 | A1 |
20160015885 | Pananen et al. | Jan 2016 | A1 |
20160034655 | Gray et al. | Feb 2016 | A1 |
20160051749 | Istoc | Feb 2016 | A1 |
20160051751 | Silkaitis et al. | Feb 2016 | A1 |
20160103960 | Hume et al. | Apr 2016 | A1 |
20160228633 | Welsch et al. | Aug 2016 | A1 |
20160350513 | Jacobson et al. | Dec 2016 | A1 |
20170262590 | Karakosta et al. | Sep 2017 | A1 |
20170286637 | Arrizza et al. | Oct 2017 | A1 |
20170319780 | Belkin et al. | Nov 2017 | A1 |
20170331735 | Jha et al. | Nov 2017 | A1 |
20180028742 | Day et al. | Feb 2018 | A1 |
20180043094 | Day et al. | Feb 2018 | A1 |
20180121613 | Connely, IV et al. | May 2018 | A1 |
20180181712 | Ensey et al. | Jun 2018 | A1 |
20190096518 | Pace | Mar 2019 | A1 |
20190147998 | Ruchti et al. | May 2019 | A1 |
20190228863 | Dharwad et al. | Jul 2019 | A1 |
20190240405 | Wehba et al. | Aug 2019 | A1 |
20190243829 | Butler et al. | Aug 2019 | A1 |
20190269852 | Kohlbrecher | Sep 2019 | A1 |
20190311803 | Kohlbrecher et al. | Oct 2019 | A1 |
20200027541 | Xavier et al. | Jan 2020 | A1 |
20200027542 | Xavier et al. | Jan 2020 | A1 |
20200027543 | Xavier et al. | Jan 2020 | A1 |
20200027548 | Xavier et al. | Jan 2020 | A1 |
20200027549 | Xavier et al. | Jan 2020 | A1 |
20200027550 | Xavier et al. | Jan 2020 | A1 |
20200027551 | Xavier et al. | Jan 2020 | A1 |
20200028837 | Xavier et al. | Jan 2020 | A1 |
20200028914 | Xavier et al. | Jan 2020 | A1 |
20200028929 | Xavier et al. | Jan 2020 | A1 |
20200035346 | Xavier et al. | Jan 2020 | A1 |
20200035355 | Xavier et al. | Jan 2020 | A1 |
Number | Date | Country |
---|---|---|
2 060 151 | Aug 1997 | CA |
2 125 300 | Oct 1999 | CA |
2 898 825 | Jul 2014 | CA |
01110843 | Aug 2003 | CO |
31 12 762 | Jan 1983 | DE |
34 35 647 | Jul 1985 | DE |
198 44 252 | Mar 2000 | DE |
199 32 147 | Jan 2001 | DE |
103 52 456 | Jul 2005 | DE |
0 319 267 | Jun 1989 | EP |
0 380 061 | Aug 1990 | EP |
0 384 155 | Aug 1990 | EP |
0 460 533 | Dec 1991 | EP |
0 564 127 | Jun 1993 | EP |
0 633 035 | Jan 1995 | EP |
0 652 528 | May 1995 | EP |
0 672 427 | Sep 1995 | EP |
0 683 465 | Nov 1995 | EP |
0 880 936 | Dec 1998 | EP |
1 157 711 | Nov 2001 | EP |
1 174 817 | Jan 2002 | EP |
0 664 102 | Apr 2002 | EP |
1 197 178 | Apr 2002 | EP |
0 830 775 | Aug 2002 | EP |
1 500 025 | Apr 2003 | EP |
2 113 842 | Nov 2009 | EP |
2 228 004 | Sep 2010 | EP |
2 243 506 | Oct 2010 | EP |
2 410 448 | Jan 2012 | EP |
2 742 961 | Jun 2014 | EP |
2 717 919 | Sep 1995 | FR |
2 285 135 | Jun 1995 | GB |
04-161139 | Jun 1992 | JP |
07-502678 | Mar 1995 | JP |
11-500643 | Jan 1999 | JP |
2000-316820 | Nov 2000 | JP |
2002-531154 | Sep 2002 | JP |
2003-016183 | Jan 2003 | JP |
2003-296173 | Oct 2003 | JP |
2005-021463 | Jan 2005 | JP |
2005-527284 | Sep 2005 | JP |
2005-284846 | Oct 2005 | JP |
2006-047319 | Feb 2006 | JP |
2006-520949 | Sep 2006 | JP |
2007-518479 | Jul 2007 | JP |
2007-525256 | Sep 2007 | JP |
2008-080036 | Apr 2008 | JP |
2008-516303 | May 2008 | JP |
2008-158622 | Jul 2008 | JP |
2008-529675 | Aug 2008 | JP |
2009-163534 | Jul 2009 | JP |
2010-502361 | Jan 2010 | JP |
2011-506048 | Mar 2011 | JP |
2012-070991 | Apr 2012 | JP |
2012-523895 | Oct 2012 | JP |
2014-068283 | Apr 2014 | JP |
WO 84001719 | May 1984 | WO |
WO 91016416 | Oct 1991 | WO |
WO 92010985 | Jul 1992 | WO |
WO 92013322 | Aug 1992 | WO |
WO 94005355 | Mar 1994 | WO |
WO 96008755 | Mar 1996 | WO |
WO 96025186 | Aug 1996 | WO |
WO-9625963 | Aug 1996 | WO |
WO 98012670 | Mar 1998 | WO |
WO 98019263 | May 1998 | WO |
WO 99051003 | Oct 1999 | WO |
WO 00013580 | Mar 2000 | WO |
WO 00053243 | Sep 2000 | WO |
WO 01014974 | Mar 2001 | WO |
WO 01033484 | May 2001 | WO |
WO 01045014 | Jun 2001 | WO |
WO 02005702 | Jan 2002 | WO |
WO 02036044 | May 2002 | WO |
WO 02049153 | Jun 2002 | WO |
WO 02049279 | Jun 2002 | WO |
WO 02069099 | Sep 2002 | WO |
WO 02081015 | Oct 2002 | WO |
WO 02088875 | Nov 2002 | WO |
WO 03006091 | Jan 2003 | WO |
WO 03050917 | Jun 2003 | WO |
WO 03091836 | Nov 2003 | WO |
WO 03094092 | Nov 2003 | WO |
WO 2004060455 | Jul 2004 | WO |
WO 2004070557 | Aug 2004 | WO |
WO 2004070562 | Aug 2004 | WO |
WO 2004072828 | Aug 2004 | WO |
WO 2005036447 | Apr 2005 | WO |
WO 2005050526 | Jun 2005 | WO |
WO 2005057175 | Jun 2005 | WO |
WO 2005066872 | Jul 2005 | WO |
WO 2007087443 | Aug 2007 | WO |
WO 2007117705 | Oct 2007 | WO |
WO 2007127879 | Nov 2007 | WO |
WO 2007127880 | Nov 2007 | WO |
WO 2008067245 | Jun 2008 | WO |
WO 2008082854 | Jul 2008 | WO |
WO 2008088490 | Jul 2008 | WO |
WO 2008097316 | Aug 2008 | WO |
WO 2008103915 | Aug 2008 | WO |
WO 2008124478 | Oct 2008 | WO |
WO 2008134146 | Nov 2008 | WO |
WO 2009016504 | Feb 2009 | WO |
WO 2009023406 | Feb 2009 | WO |
WO 2009023407 | Feb 2009 | WO |
WO 2009023634 | Feb 2009 | WO |
WO 2009036327 | Mar 2009 | WO |
WO 2009049252 | Apr 2009 | WO |
WO 2010017279 | Feb 2010 | WO |
WO 2010033919 | Mar 2010 | WO |
WO 2010053703 | May 2010 | WO |
WO 2010075371 | Jul 2010 | WO |
WO 2010099313 | Sep 2010 | WO |
WO 2010114929 | Oct 2010 | WO |
WO 2010119409 | Oct 2010 | WO |
WO 2010124127 | Oct 2010 | WO |
WO 2010130992 | Nov 2010 | WO |
WO 2010135646 | Nov 2010 | WO |
WO 2010135654 | Nov 2010 | WO |
WO 2010135686 | Nov 2010 | WO |
WO 2011005633 | Jan 2011 | WO |
WO 2011022549 | Feb 2011 | WO |
WO 2012048833 | Apr 2012 | WO |
WO 2012049214 | Apr 2012 | WO |
WO 2012049218 | Apr 2012 | WO |
WO 2012120078 | Sep 2012 | WO |
WO 2012140547 | Oct 2012 | WO |
WO 2012164556 | Dec 2012 | WO |
WO 2012170942 | Dec 2012 | WO |
WO 2013045506 | Apr 2013 | WO |
WO 2014100736 | Jun 2014 | WO |
WO 2014131729 | Sep 2014 | WO |
WO 2014131730 | Sep 2014 | WO |
WO 2015124569 | Aug 2015 | WO |
WO 2017176928 | Oct 2017 | WO |
Entry |
---|
McKesson Automation and ALARIS Medical Systems Developing Point-of-Care Bar Coding Solution to Improve IV Medication Safety, Dec. 9, 2002, PR Newswire. (Year: 2002). |
Bektas et al., “Bluetooth Communication Employing Antenna Diversity”, Proceedings of Eight IEEE International Symposium on Computers and Communication, Jul. 2003, pp. 6. |
Akridge, Jeannie, “New Pumps Outsmart User Error”, Healthcare Purchasing News, Apr. 2011, pp. 10, http://web.archive.org/web/20110426122450/http://www.hpnonline.com/inside/2011-04/1104-OR-Pumps.html. |
Alur et al., “Formal Specifications and Analysis of the Computer-Assisted Resuscitation Algorithm (CARA) Infusion Pump Control System”, International Journal on Software Tools for Technology Transfer, Feb. 2004, vol. 5, No. 4, pp. 308-319. |
Aragon, Daleen RN, Ph.D., CCRN, “Evaluation of Nursing Work Effort and Perceptions About Blood Glucose Testing in Tight Glycemic Control”, American Journal of Critical Care, Jul. 2006, vol. 15, No. 4, pp. 370-377. |
ASHP Advantage, “Improving Medication Safety in Health Systems Through Innovations in Automation Technology”, Proceedings of Educational Symposium and Educational Sessions during the 39th ASHP Midyear Clinical Meeting, Dec. 5-9, 2004, Orlando, FL, pp. 28. |
Beard et al., “Total Quality Pain Management: History, Background, Resources”, Abbott Laboratories, TQPM Survey History, available Feb. 2015 or earlier, pp. 1-3. |
Bequette, Ph.D., “A Critical Assessment of Algorithms and Challenges in the Development of a Closed-Loop Artificial Pancreas”, Diabetes Technology & Therapeutics, Feb. 28, 2005, vol. 7, No. 1, pp. 28-47. |
Bequette, B. Wayne, Ph.D., “Analysis of Algorithms for Intensive Care Unit Blood Glucose Control”, Journal of Diabetes Science and Technology, Nov. 2007, vol. 1, No. 6, pp. 813-824. |
Braun, “Infusomat® Space and Accessories”, Instructions for Use, Nov. 2010, pp. 68. http:///corp.bbraun.ee/Extranet/infusioonipumbad/Kasutusiuhendid/Vanad/Kasutusiuhend-Infusomat_Space(vers688J.inglise_k).pdf. |
Brownlee, Seth, “Product Spotlight: The Plum A+ with Hospira MedNet Infusion System”, PP&P Magazine, Dec. 2005, vol. 2, No. 7, pp. 2. |
Cannon, MD et al., “Automated Heparin-Delivery System to Control Activated Partial Thromboplastin Time”, Circulation, Feb. 16, 1999, vol. 99, pp. 751-756. |
Cardinal Health, “Alaris® Syringe Pumps” Technical Service Manual, Copyright 2002-2006, Issue 9, pp. 1-88, http://www.frankshospitalworkshop.com/equipment/documents/infusion_pumps/service_manuals/Cardinal_Alaris_-_Service_Manual.pdf. |
“CareAware® Infusion Management”, Cerner Store, as printed May 12, 2011, pp. 3, https://store.cemer.com/items/7. |
Chen et al., “Enabling Location-Based Services on Wireless LANs”, The 11th IEEE International Conference on Networks, ICON 2003, Sep. 28-Oct. 1, 2003, pp. 567-572. |
“Computer Dictionary”, Microsoft Press, Third Edition, Microsoft Press, 1997, pp. 430 & 506. |
Crawford, Anne J., MSN, RNC, “Building a Successful Quality Pain Service: Using Patient Satisfaction Data and the Clinical Practice Guideline”, USA, 1995, pp. 1-6. |
Crocker et al., “Augmented BNF for Syntax Specifications: ABNF”, Network Working Group, Standards Track, Jan. 2008, pp. 16. |
Davidson et al., “A Computer-Directed Intravenous Insulin System Shown to be Safe, Simple, and Effective in 120,618 h of Operation”, Diabetes Care, Oct. 2005, vol. 28, No. 10, pp. 2418-2423. |
Davies, T., “Cordless Data Acquisition in a Hospital Environment”, IEE Colloquium on Cordless Computing—Systems and User Experience, 1993, pp. 4. |
Dayhoff et al., “Medical Data Capture and Display: The Importance of Clinicians' Workstation Design”, AMIA, Inc., 1994, pp. 541-545. |
Diabetes Close Up, Close Concerns AACE Inpatient Management Conference Report, Consensus Development Conference on Inpatient Diabetes and Metabolic Control, Washington, D.C., Dec. 14-16, 2003, pp. 1-32. |
East PhD et al., “Digital Electronic Communication Between ICU Ventilators and Computers and Printers”, Respiratory Care, Sep. 1992, vol. 37, No. 9, pp. 1113-1122. |
Einhorn, George W., “Total Quality Pain Management: A Computerized Quality Assessment Tool for Postoperative Pain Management”, Abbott Laboratories, Chicago, IL, Mar. 2, 2000, pp. 1-4. |
Eskew et al., “Using Innovative Technologies to Set New Safety Standards for the Infusion of Intravenous Medications”, Hospital Pharmacy, 2002, vol. 37, No. 11, pp. 1179-1189. |
Philips, “IntelliSpace Event Management and IntelliVue Patient Monitoring”, Release 10, 2011, http://incenter.medical.philips.com/docllb/enc/fetch/2000/4504/577242/577243/577247/582646/583147/8359175/Philips_Patient_Monitoring_and_IntelliSpace_Event_Management_Interoperability.pdf%3fnodeid%3d8508574%26vemum%3d-2, pp. 2. |
Felleiter et al., “Data Processing in Prehospital Emergency Medicine”, International journal of Clinical Monitoring and Computing, Feb. 1995, vol. 12, No. 1, pp. 37-41. |
Fogt et al., Development and Evaluation of a Glucose Analyzer for a Glucose-Controlled Insulin Infusion System (Biostator®), Clinical Chemistry, 1978, vol. 24, No. 8, pp. 1366-1372. |
Gabel et al., “Camp: A Common API for Measuring Performance”, 21st Large Installations System Administration Conference (LISA '07), 2007, pp. 49-61. |
Gage et al., “Automated Anesthesia Surgery Medical Record System”, International Journal of Clinical Monitoring and Computing, Dec. 1990, vol. 7, No. 4, pp. 259-263. |
Galt et al., “Personal Digital Assistant-Based Drug Information Sources: Potential to Improve Medication Safety”, Journal of Medical Library Association, Apr. 2005, vol. 93, No. 2, pp. 229-236. |
Gardner, Ph.D. et al., “Real Time Data Acquisition: Recommendations for the Medical Information Bus (MIB)”, 1992, pp. 813-817. |
“General-Purpose Infusion Pumps”, Health Devices, EXRI Institute, Oct. 1, 2002, vol. 31, No. 10, pp. 353-387. |
Givens et al., “Exploring the Internal State of User Interfaces by Combining Computer Vision Techniques with Grammatical Inference”, Proceedings of the 2013 International Conference on Software Engineering, San Francisco, CA, May 18-26, 2013, pp. 1165-1168. |
Glaeser, “A Hierarchical Minicomputer System for Continuous Post-Surgical Monitoring”, Computers and Biomedical Research, Aug. 31, 1975, pp. 336-361. |
Goldberg et al., “Clinical Results of an Updated Insulin Infusion Protocol in Critically Ill Patients”, Diabetes Spectrum, 2005, vol. 18, No. 3, pp. 188-191. |
Gomez et al., “CLAM: Connection-Less, Lightweight, and Multiway Communication Support for Distributed Computing”, Computer Science, 1997, vol. 1199, pp. 227-240. |
“GPS Tracker for Medical Equipment”, http://www.trackingsystem.com/forbusinesses/corporate-trackingsystem/1098-gps-tracker-formedicalequipment.html, Mar. 15, 2015, pp. 2. |
Graseby, “Model 3000/500 and Micro 3100/505: Volumetric Infusion Pump”, Technical Service Manual, Graseby Medical Ltd., Apr. 2002, Issue A, pp. 160. |
Graseby, “Model 3000/500 and Micro 3100/505: Volumetric Infusion Pump: Illustrated Parts List for Pump Serial Nos. from 3000 to 59,999”, Technical Service Manual, Graseby Medical Ltd., Apr. 2002, Issue A, pp. 71. |
Halpern et al., “Changes in Critical Care Beds and Occupancy in the United States 1985-2000: Differences Attributable to Hospital Size”, Critical Care Medical, Aug. 2006, vol. 34, No. 8, pp. 2105-2112. |
Hamann et al., “PUMPSIM: A Software Package for Simulating Computer-Controlled Drug Infusion Pumps”, Annual International Conference of the IEEE Engineering in Medicine and Biology Society, 1990, vol. 12, No. 5, pp. 2019-2020. |
Hasegawa et al., “On a Portable Memory Device for Physical Activities and Informations of Maternal Perception”, Journal of Perinatal Medicine, 1988, vol. 16, No. 4, pp. 349-356. |
Hawley et al., “Clinical Implementation of an Automated Medical Information Bus in an Intensive Care Unit”, Proceedings of the Annual Symposium on Computer Application in Medical Care, Nov. 9, 1988, pp. 621-624. |
Hayes-Roth et al., “Guardian: A Prototype Intelligent Agent for Intensive-Care Monitoring”, Artificial Intelligence in Medicine, vol. 4, Dec. 31, 1992, pp. 165-185. |
Hospira, GemStar® Pain Management Infusion System 9-084-PR1-2-2, www.hospira.com/products/gemstar_painmanagement.aspx, Jan. 28, 2010, pp. 1-2. |
Introducing Abbott TQPM (Total Quality Pain Management), Abbott Laboratories, Abbott Park, IL, May 2000, pp. 1-4. |
“Infusion Pump”, Wikipedia.org, https://web.archive.org/web/20140703024932/https://en.wikipedia.org/wiki/infusion_pump, as last modified Mar. 27, 2014, pp. 3. |
Isaka et al., “Control Strategies for Arterial Blood Pressure Regulation”, IEEE Transactions on Biomedical Engineering, Apr. 1993, vol. 40, No. 4, pp. 353-363. |
Johnson et al., “Using BCMA Software to Improve Patient Safety In Veterans Administration Medical Centers”, Journal of Healthcare Information Management, Dec. 6, 2004, vol. 16, No. 1, pp. 46-51. |
Kent Displays, “Reflex™ Electronic Skins”, Product Brief 25127B, 2009, pp. 2. |
Kent Displays, “Reflex Electronic Skins Engineering Evaluation Kit”, 25136A, Mar. 10, 2009. |
Lefkowitz et al., “A Trial of the Use of Bar Code Technology to Restructure a Drug Distribution and Administration System”, Hospital Pharmacy, Mar. 31, 1991, vol. 26, No. 3, pp. 239-242. |
Lenssen et al., “Bright Color Electronic Paper Technology and Applications”, IDS '09 Publication EP1-2 (Phillips Research), 2009, pp. 529-532. |
Leveson, Nancy, “Medical Devices: The Therac-25”, Appendix A, University of Washington, 1995, pp. 49. |
Linkens, D.A. “Computer Control for Patient Care”, Computer Control of Real-Time Processes, IEE Control Engineering Series 41, 1990, Ch. 13, pp. 216-238. |
Mako Hill et al., “The Official Ubuntu Book”, Shoeisha Co., Ltd., 1st Edition, Jun. 11, 2007, pp. 115 to 125. |
Marshall, et al., “New Microprocessor-Based Insulin Controller”, IEEE Transactions on Biomedical Engineering, Nov. 1983, vol. BME-30, No. 11, pp. 689-695. |
Martino et al., “Automation of a Medical Intensive Care Environment with a Flexible Configuration of Computer Systems”, Proceedings of the Annual Symposium on Computer Application in Medical Care, Nov. 5, 1980, vol. 3, pp. 1562-1568. |
Matsunaga et al., “On the Use of Machine Learning to Predict the Time and Resources Consumed by Applications”, 2010 10th IEEE/ACM International Conference on Cluster, Cloud and Grid Computing (CCGrid), May 17-20, 2010, pp. 495-504. |
MAUSETH et al., “Proposed Clinical Application for Tuning Fuzzy Logic Controller of Artificial Pancreas Utilizing a Personalization Factor”, Journal of Diabetes Science and Technology, Jul. 2010, vol. 4, No. 4, pp. 913-922. |
Medfusion™, “Medfusion Syringe Infusion Pump Model 4000”, Operator's Manual, Software Version V1.1, Sep. 2011, pp. 154. http://www.medfusionpump.com/assets/literature/manuals/Operators_Manual_4000_40-5760-51A.pdf. |
Metnitz et al., “Computer Assisted Data Analysis in Intensive Care: the ICDEV Project-Development of a Scientific Database System for Intensive Care”, International Journal of Clinical Monitoring and Computing, Aug. 1995, vol. 12, No. 3, pp. 147-159. |
Micrel Medical Devices, “MP Daily +” http://web.archive.org/web/20130803235715/http://www.micrelmed.com/index.aspx?productid=9 as archived Aug. 3, 2013 in 1 page. |
Moghissi, Etie, MD, FACP, FACE, “Hyperglycemia in Hospitalized Patients”, A Supplement to ACP Hospitalist, Jun. 15, 2008, pp. 32. |
Murray, Jr. et al., “Automated Drug Identification System (during surgery)”, IEEE Proceedings of Southeastcon '91, Apr. 7-10, 1991, pp. 265. |
Nicholson et al., “Smart' Infusion Apparatus for Computation and Automated Delivery of Loading, Tapering, and Maintenance Infusion Regimens of Lidocaine, Procainamide, and Theophylline”, Proceedings of The Seventh Annual Symposium on Computer Applications in Medical Care, Oct. 1983, pp. 212-213. |
Nolan et al., “The P1073 Medical Information Bus Standard: Overview and Benefits for Clinical Users”, 1990, pp. 216-219. |
Omnilink Systems, Inc., “Portable Medical Equipment Tracking”, http://www.omnilink.com/portablemedicalequipmenttracking/, Mar. 15, 2015, pp. 2. |
O'Shea, Kristen L., “Infusion Management: Working Smarter, Not Harder”, Hospital Pharmacy, Apr. 2013, vol. 48, No. 3, pp. S1-S14. |
Package Management in Debian GNU/Linux, Debian GNU/Linux Expert Desktop Use Special, Giutsu-Hyohron Co., Ltd., First Edition, Sep. 25, 2004, pp. 183-185. |
Passos et al., “Distributed Software Platform for Automation and Control of General Anaesthesia”, Eighth International Symposium on Parallel and Distributed Computing, ISPDC '09, Jun. 30-Jul. 4, 2009, pp. 8. |
Pretty et al., “Hypoglycemia Detection in Critical Care Using Continuous Glucose Monitors: An in Silico Proof of Concept Analysis”, Journal of Diabetes Science and Technology, Jan. 2010, vol. 4, No. 1, pp. 15-24. |
Rappoport, Arthur E., “A Hospital Patient and Laboratory machine-Readable Identification System (MRIS) Revisited”, Journal of Medical Systems, Apr. 1984, vol. 8, Nos. 1/2, pp. 133-156. |
Ritchie et al., “A Microcomputer Based Controller for Neuromuscular Block During Surgery”, Annals of Biomedical Engineering, Jan. 1985, vol. 13, No. 1, pp. 3-15. |
Saager et al., “Computer-Guided Versus Standard Protocol for Insulin Administration in Diabetic Patients Undergoing Cardiac Surgery”, Annual Meeting of the American Society of Critical Care Anesthesiologists, Oct. 13, 2006. |
Sanders et al., “The Computer in a Programmable Implantable Medication System (PIMS)”, Proceedings of the Annual Symposium on Computer Application in Medical Care, Nov. 2, 1982, pp. 682-685. |
Schilling et al., “Optimizing Outcomes! Error Prevention and Evidence-Based Practice with IV Medications”, A Pro-Ce Publication, Hospira, Inc., Feb. 6, 2012, pp. 56. |
Schulze et al., “Advanced Sensors Technology Survey”, Final Report, Feb. 10, 1992, pp. 161. |
Scott, et al., “Using Bar-Code Technology to Capture Clinical Intervention Data in a Hospital with a Stand-Alone Pharmacy Computer System”, Mar. 15, 1996, American Journal of Health-System Pharmacy, vol. 53, No. 6, pp. 651-654. |
Sebald et al., “Numerical Analysis of a Comprehensive in Silico Subcutaneous Insulin Absorption Compartmental Model”, 31st Annual International Conference of the IEEE Engineering in Medicine and Biology Society, Sep. 2-6, 2009, pp. 3901-3904. |
Shabot, M. Michael, “Standardized Acquisition of Bedside Data: The IEEE P1073 Medical Information Bus”, International Journal of Clinical Monitoring and Computing, vol. 6, Sep. 27, 1989, pp. 197-204. |
Sheppard, Louis, Ph.D., “Automation of the Infusion of Drugs Using Feedback Control”, Journal of Cardiothoracic and Vascular Anesthesia, Feb. 28, 1989, vol. 3, No. 1, pp. 1-3. |
Sheppard, Louis, Ph.D., “Computer Control of the Infusion of Vasoactive Drugs”, Annals of Biomedical Engineering, Jul. 1980, vol. 8, No. 4-6, pp. 431-444. |
Sheppard, Louis, Ph.D., “The Application of Computers to the Measurement, Analysis, and Treatment of Patients Following Cardiac Surgical Procedures”, The University of Alabama in Birmingham, Oct. 31, 1977, pp. 297-300. |
Sheppard, Louis, Ph.D., “The Computer in the Care of Critically Ill Patients”, Proceedings of the IEEE, Sep. 1979, vol. 67, No. 9, pp. 1300-1306. |
“SIGMA SPECTRUM: Operator's Manual”, Oct. 2009, pp. 72. http://static.medonecapital.com/manuals/userManuals/Sigma-Spectrum-Operator-Manual-October-2009.pdf. |
Simonsen, Michael Ph.D., POC Testing, New Monitoring Strategies on Fast Growth Paths in European Healthcare Arenas, Biomedical Business & Technology, Jan. 2007, vol. 30, No. 1, pp. 1-36. |
Siv-Lee et al., “Implementation of Wireless ‘Intelligent’ Pump IV Infusion Technology in a Not-for-Profit Academic Hospital Setting”, Hospital Pharmacy, Sep. 2007, vol. 42, No. 9, pp. 832-840. http://www.thomasiand.com/hpj4209-832.pdf. |
Slack, W.V., “Information Technologies for Transforming Health Care”, https://www.andrew.cmu.edu/course/90-853/medis.dir/otadocs.dir/03ch2.pdf, Ch. 2, 1995, pp. 29-78. |
Smith, Joe, “Infusion Pump Informatics”, CatalyzeCare: Transforming Healthcare, as printed May 12, 2011, pp. 2. |
Sodder, Lisa, “A Center Keeps Medicine in Right Hands”, Dec. 4, 1999, pp. 1-2. |
Stitt, F.W., “The Problem-Oriented Medical Synopsis: a Patient-Centered Clinical Information System”, Proceedings of the Annual Symposium on Computer Application in Medical Care, 1994, pp. 88-92. |
Stokowski, Laura A. RN, MS, “Using Technology to Improve Medication Safety in the Newborn Intensive Care Unit”, Advances in Neonatal Care, Dec. 2001, vol. 1, No. 2, pp. 70-83. |
Sutton et al., “The Syntax and Semantics of the PROforma Guideline Modeling Language”, Journal of the American Medical Informatics Association, Sep./Oct. 2003, vol. 10, No. 5, pp. 433-443. |
Szeinbach et al., “Automated Dispensing Technologies: Effect on Managed Care”, Journal of Managed Care Pharmacy (JMCP), Sep./Oct. 1995, vol. 1, No. 2, pp. 121-127. |
Szolovits et al., “Guardian Angel: Patient-Centered Health Information Systems”, Technical Report MIT/LCS/TR-604, Massachusetts Institute of Technology Laboratory for Computer Science, May 1994, pp. 39. |
Van Den Berghe, M.D., Ph.D., et al., “Intensive Insulin Therapy in Critically Ill Patients”, The New England Journal of Medicine, Nov. 8, 2001, vol. 345, No. 19, pp. 1359-1367. |
Van Den Berghe, M.D., Ph.D., et al., “Intensive Insulin Therapy in the Medical ICU”, The New England Journal of Medicine, Feb. 2, 2006, vol. 354, No. 5, pp. 449-461. |
Van Der Maas et al., “Requirements for Medical Modeling Languages”, Journal of the American Medical Informatics Association, Mar./Apr. 2001, vol. 8, No. 2, pp. 146-162. |
Villalobos et al., “Computerized System in Intensive Care medicine”, Medical Informatics, vol. 11, No. 3, 1986, pp. 269-275. |
Wilkins et al., “A Regular Language: The Annotated Case Report Form”, PPD Inc., PharmaSUG2011—Paper CD18, 2011, pp. 1-9. |
Ying et al., “Regulating Mean Arterial Pressure in Postsurgical Cardiac Patients. A Fuzzy Logic System to Control Administration of Sodium Nitroprusside”, IEEE Engineering in Medicine and Biology Magazine, vol. 13, No. 5, Nov.-Dec. 1994, pp. 671-677. |
Yue, Ying Kwan, “A Healthcare Failure Mode and Effect Analysis on the Safety of Secondary Infusions”, Thesis, Institute of Biomaterials and Biomedical Engineering, University of Toronto, 2012, pp. 168. |
Yurkonis et al., “Computer Simulation of Adaptive Drug Infusion”, IEEE Transactions on Biomedical Engineering, vol. BME-34, No. 8, Aug. 1987, pp. 633-635. |
Zakariah et al., “Combination of Biphasic Transmittance Waveform with Blood Procalcitonin Levels for Diagnosis of Sepsis in Acutely Ill Patients”, Critical Care Medicine, 2008, vol. 36, No. 5, pp. 1507-1512. |
International Preliminary Report on Patentability and Written Opinion received in PCT Application No. PCT/US2004/037900, dated May 15, 2006 in 5 pages. |
International Search Report and Written Opinion received in PCT Application No. PCT/US2004/033409, dated Sep. 13, 2015 in 11 pages. |
International Preliminary Report on Patentability and Written Opinion received in PCT Application No. PCT/US2004/033409, dated Apr. 10, 2006 in 7 pages. |
“File Verification”, Wikipedia.org, dated Oct. 11, 2011 in 2 pages, https://en.wikipedia.org/w/index.php?title=File_verification&oldid=455048290. |
“Software Versioning”, Wikipedia.org, dated Oct. 16, 2011 in 11 pages, https://en.wikipedia.org/w/index.php?title=Software_versioning&oldid=455859110. |
Number | Date | Country | |
---|---|---|---|
20170274140 A1 | Sep 2017 | US |
Number | Date | Country | |
---|---|---|---|
60527550 | Dec 2003 | US | |
60519646 | Nov 2003 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 10783877 | Feb 2004 | US |
Child | 13301518 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 13301518 | Nov 2011 | US |
Child | 15435223 | US |